{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:03:34Z","timestamp":1794258214681,"version":"4.9.0"},"reference-count":338,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Traditional Chinese Medicine scientific research project(Joint project of Chongqing Health Commission and Science and Technology Bureau"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"DOI":"10.1007\/s10856-026-07012-7","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:34:50Z","timestamp":1770651290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Smart nanoparticle delivery systems for curcumin: a targeted strategy to enhance anticancer efficacy and bioavailability"],"prefix":"10.1007","volume":"37","author":[{"given":"Yang","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanxin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiong","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"7012_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7012_CR2","doi-asserted-by":"publisher","first-page":"11694","DOI":"10.3390\/ijms222111694","volume":"22","author":"MA Papie\u017c","year":"2021","unstructured":"Papie\u017c MA, Krzy\u015bciak W. Biological therapies in the treatment of cancer-update and new directions. Int J Mol Sci. 2021;22:11694.","journal-title":"Int J Mol Sci"},{"key":"7012_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s13346-023-01485-7","volume":"14","author":"J Tao","year":"2024","unstructured":"Tao J, Yuan X, Zheng M, Jiang Y, Chen Y, Zhang F, et al. Bibliometric and visualized analysis of cancer nanomedicine from 2013 to 2023. Drug Deliv Transl Res. 2024;14:1708\u201324.","journal-title":"Drug Deliv Transl Res"},{"key":"7012_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.14336\/AD.2022.1101","volume":"14","author":"M Hao","year":"2023","unstructured":"Hao M, Chu Y, Lei J, Yao Z, Wang P, Chen Z, et al. Pharmacological mechanisms and clinical applications of curcumin: update. Aging Dis. 2023;14:716\u201349.","journal-title":"Aging Dis"},{"key":"7012_CR5","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.7150\/ijbs.33710","volume":"15","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Zhou L, Yu F, Ding H, Li P, et al. Potential mechanisms of action of curcumin for cancer prevention: focus on cellular signaling pathways and miRNAs. Int J Biol Sci. 2019;15:1200\u201314.","journal-title":"Int J Biol Sci"},{"key":"7012_CR6","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.3390\/ijms21186619","volume":"21","author":"K Hassanzadeh","year":"2020","unstructured":"Hassanzadeh K, Buccarello L, Dragotto J, Mohammadi A, Corbo M, Feligioni M. Obstacles against the marketing of curcumin as a drug. Int J Mol Sci. 2020;21:6619.","journal-title":"Int J Mol Sci"},{"key":"7012_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3390\/antibiotics11020135","volume":"11","author":"M Uro\u0161evi\u0107","year":"2022","unstructured":"Uro\u0161evi\u0107 M, Nikoli\u0107 L, Gaji\u0107 I, Nikoli\u0107 V, Dini\u0107 A, Miljkovi\u0107 V. Curcumin: biological activities and modern pharmaceutical forms. Antibiotics. 2022;11:135.","journal-title":"Antibiotics"},{"key":"7012_CR8","first-page":"1058","volume":"61","author":"C Ireson","year":"2001","unstructured":"Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61:1058\u201364.","journal-title":"Cancer Res"},{"key":"7012_CR9","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1158\/1055-9965.EPI-07-2693","volume":"17","author":"SK Vareed","year":"2008","unstructured":"Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomark Prev. 2008;17:1411\u20137.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7012_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/pharmaceutics16050637","volume":"16","author":"J Yakubu","year":"2024","unstructured":"Yakubu J, Pandey AV. Innovative delivery systems for curcumin: exploring nanosized and conventional formulations. Pharmaceutics. 2024;16:637.","journal-title":"Pharmaceutics"},{"key":"7012_CR11","doi-asserted-by":"publisher","first-page":"4275","DOI":"10.2147\/IJN.S410688","volume":"18","author":"M Huang","year":"2023","unstructured":"Huang M, Zhai BT, Fan Y, Sun J, Shi YJ, Zhang XF, et al. Targeted drug delivery systems for curcumin in breast cancer therapy. Int J Nanomed. 2023;18:4275\u2013311.","journal-title":"Int J Nanomed"},{"key":"7012_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.addr.2010.04.009","volume":"63","author":"J Fang","year":"2011","unstructured":"Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63:136\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"7012_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-018-0392-8","volume":"16","author":"JK Patra","year":"2018","unstructured":"Patra JK, Das G, Fraceto LF, Campos E, Rodriguez-Torres M, Acosta-Torres LS, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16:71.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR14","doi-asserted-by":"publisher","first-page":"e202302030","DOI":"10.1002\/cbdv.202302030","volume":"21","author":"N Chelimela","year":"2024","unstructured":"Chelimela N, Alavala RR, Satla SR. Curcumin\u2014bioavailability enhancement by prodrug approach and novel formulations. Chem Biodivers. 2024;21:e202302030.","journal-title":"Chem Biodivers"},{"key":"7012_CR15","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1039\/C5CS00798D","volume":"45","author":"M Karimi","year":"2016","unstructured":"Karimi M, Ghasemi A, Sahandi Zangabad P, Rahighi R, Moosavi Basri SM, Mirshekari H, et al. Smart micro\/nanoparticles in stimulus-responsive drug\/gene delivery systems. Chem Soc Rev. 2016;45:1457\u2013501.","journal-title":"Chem Soc Rev"},{"key":"7012_CR16","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.3390\/pharmaceutics15051482","volume":"15","author":"Q Leng","year":"2023","unstructured":"Leng Q, Imtiyaz Z, Woodle MC, Mixson AJ. Delivery of chemotherapy agents and nucleic acids with pH-dependent nanoparticles. Pharmaceutics. 2023;15:1482.","journal-title":"Pharmaceutics"},{"key":"7012_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fchem.2020.00647","volume":"8","author":"M Li","year":"2020","unstructured":"Li M, Zhao G, Su WK, Shuai Q. Enzyme-responsive nanoparticles for anti-tumor drug delivery. Front Chem. 2020;8:647.","journal-title":"Front Chem"},{"key":"7012_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jconrel.2019.07.004","volume":"308","author":"M Shahriari","year":"2019","unstructured":"Shahriari M, Zahiri M, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M. Enzyme responsive drug delivery systems in cancer treatment. J Control Release. 2019;308:172\u201389.","journal-title":"J Control Release"},{"key":"7012_CR19","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1039\/C7CS00663B","volume":"47","author":"J Mu","year":"2018","unstructured":"Mu J, Lin J, Huang P, Chen X. Development of endogenous enzyme-responsive nanomaterials for theranostics. Chem Soc Rev. 2018;47:5554\u201373.","journal-title":"Chem Soc Rev"},{"key":"7012_CR20","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.3390\/polym15102292","volume":"15","author":"H An","year":"2023","unstructured":"An H, Deng X, Wang F, Xu P, Wang N. Dendrimers as nanocarriers for the delivery of drugs obtained from natural products. Polymers. 2023;15:2292.","journal-title":"Polymers"},{"key":"7012_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","volume":"15","author":"S Hossen","year":"2019","unstructured":"Hossen S, Hossain MK, Basher MK, Mia M, Rahman MT, Uddin MJ. Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review. J Adv Res. 2019;15:1\u201318.","journal-title":"J Adv Res"},{"key":"7012_CR22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jsps.2020.01.004","volume":"28","author":"M Alsehli","year":"2020","unstructured":"Alsehli M. Polymeric nanocarriers as stimuli-responsive systems for targeted tumor (cancer) therapy: recent advances in drug delivery. Saudi Pharm J. 2020;28:255\u201365.","journal-title":"Saudi Pharm J"},{"key":"7012_CR23","doi-asserted-by":"publisher","first-page":"111578","DOI":"10.1016\/j.biopha.2021.111578","volume":"139","author":"D Dourado","year":"2021","unstructured":"Dourado D, Freire DT, Pereira DT, Amaral-Machado L, N Alencar \u00c9, de Barros A, et al. Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed Pharmacother. 2021;139:111578.","journal-title":"Biomed Pharmacother"},{"key":"7012_CR24","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/nano14080672","volume":"14","author":"S Jacob","year":"2024","unstructured":"Jacob S, Kather FS, Morsy MA, Boddu S, Attimarad M, Shah J, et al. Advances in nanocarrier systems for overcoming formulation challenges of curcumin: current insights. Nanomaterials. 2024;14:672.","journal-title":"Nanomaterials"},{"key":"7012_CR25","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/plants11162137","volume":"11","author":"M Younes","year":"2022","unstructured":"Younes M, Mardirossian R, Rizk L, Fazlian T, Khairallah JP, Sleiman C, et al. The synergistic effects of curcumin and chemotherapeutic drugs in inhibiting metastatic, invasive and proliferative pathways. Plants. 2022;11:2137.","journal-title":"Plants"},{"key":"7012_CR26","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.3390\/molecules24142527","volume":"24","author":"BL Tan","year":"2019","unstructured":"Tan BL, Norhaizan ME. Curcumin combination chemotherapy: the implication and efficacy in cancer. Molecules. 2019;24:2527.","journal-title":"Molecules"},{"key":"7012_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3390\/cancers12040974","volume":"12","author":"SH Qin","year":"2020","unstructured":"Qin SH, Lau A, Liang ZL, Tan HW, Ji YC, Zhong QH, et al. Resveratrol promotes tumor microvessel growth via endoglin and extracellular signal-regulated kinase signaling pathway and enhances the anticancer efficacy of gemcitabine against lung cancer. Cancers. 2020;12:974.","journal-title":"Cancers"},{"key":"7012_CR28","doi-asserted-by":"publisher","first-page":"1295323","DOI":"10.3389\/fbioe.2023.1295323","volume":"11","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xiao M, Guo F, Yan Y, Tian H, Zhang Q, et al. Biodegradable polyester-based nano drug delivery system in cancer chemotherapy: a review of recent progress (2021-2023). Front Bioeng Biotechnol. 2023;11:1295323.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR29","doi-asserted-by":"publisher","first-page":"1253048","DOI":"10.3389\/fbioe.2023.1253048","volume":"11","author":"S Sun","year":"2023","unstructured":"Sun S, Wang YH, Gao X, Wang HY, Zhang L, Wang N, et al. Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review. Front Bioeng Biotechnol. 2023;11:1253048.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fphar.2020.00487","volume":"11","author":"A Karthikeyan","year":"2020","unstructured":"Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharm. 2020;11:487.","journal-title":"Front Pharm"},{"key":"7012_CR31","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.2147\/IJN.S454004","volume":"19","author":"MR Zhang","year":"2024","unstructured":"Zhang MR, Fang LL, Guo Y, Wang Q, Li YJ, Sun HF, et al. Advancements in stimulus-responsive co-delivery nanocarriers for enhanced cancer immunotherapy. Int J Nanomed. 2024;19:3387\u2013404.","journal-title":"Int J Nanomed"},{"key":"7012_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2174\/0109298673305616240610153554","volume":"32","author":"Y Cheng","year":"2025","unstructured":"Cheng Y, Xu Q, Yu M, Dang C, Deng L, Chen H. Curcumin nanoparticles-related non-invasive tumor therapy, and cardiotoxicity relieve. Curr Med Chem. 2025;32:447\u201367.","journal-title":"Curr Med Chem"},{"key":"7012_CR33","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3390\/cancers16081554","volume":"16","author":"V Zoi","year":"2024","unstructured":"Zoi V, Kyritsis AP, Galani V, Lazari D, Sioka C, Voulgaris S, et al. The role of curcumin in cancer: a focus on the PI3K\/Akt pathway. Cancers. 2024;16:1554.","journal-title":"Cancers"},{"key":"7012_CR34","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1096\/fj.201900077R","volume":"33","author":"M Guerrero-Hue","year":"2019","unstructured":"Guerrero-Hue M, Garc\u00eda-Caballero C, Palomino-Antol\u00edn A, Rubio-Navarro A, V\u00e1zquez-Carballo C, Herencia C, et al. Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J. 2019;33:8961\u201375.","journal-title":"FASEB J"},{"key":"7012_CR35","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.3390\/cancers13143427","volume":"13","author":"R Farghadani","year":"2021","unstructured":"Farghadani R, Naidu R. Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer. Cancers. 2021;13:3427.","journal-title":"Cancers"},{"key":"7012_CR36","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/nu11122989","volume":"11","author":"WNB Wan Mohd Tajuddin","year":"2019","unstructured":"Wan Mohd Tajuddin WNB, Lajis NH, Abas F, Othman I, Naidu R. Mechanistic understanding of curcumin\u2019s therapeutic effects in lung cancer. Nutrients. 2019;11:2989.","journal-title":"Nutrients"},{"key":"7012_CR37","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-018-0959-0","volume":"37","author":"Y Liu","year":"2018","unstructured":"Liu Y, Wang X, Zeng S, Zhang X, Zhao J, Zhang X, et al. The natural polyphenol curcumin induces apoptosis by suppressing STAT3 signaling in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2018;37:303.","journal-title":"J Exp Clin Cancer Res"},{"key":"7012_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23840-2","volume":"8","author":"YI Hahn","year":"2018","unstructured":"Hahn YI, Kim SJ, Choi BY, Cho KC, Bandu R, Kim KP, et al. Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells. Sci Rep. 2018;8:6409.","journal-title":"Sci Rep"},{"key":"7012_CR39","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1080\/15384101.2020.1784599","volume":"19","author":"H Zhu","year":"2020","unstructured":"Zhu H, Wang X, Wang X, Liu B, Yuan Y, Zuo X. Curcumin attenuates inflammation and cell apoptosis through regulating NF-\u03baB and JAK2\/STAT3 signaling pathway against acute kidney injury. Cell Cycle. 2020;19:1941\u201351.","journal-title":"Cell Cycle"},{"key":"7012_CR40","doi-asserted-by":"publisher","first-page":"e0125627","DOI":"10.1371\/journal.pone.0125627","volume":"10","author":"YS Devi","year":"2015","unstructured":"Devi YS, DeVine M, DeKuiper J, Ferguson S, Fazleabas AT. Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells. PLoS ONE. 2015;10:e0125627.","journal-title":"PLoS ONE"},{"key":"7012_CR41","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s10787-025-01643-y","volume":"33","author":"D Khayatan","year":"2025","unstructured":"Khayatan D, Razavi SM, Arab ZN, Nasoori H, Fouladi A, Pasha A, et al. Targeting mTOR with curcumin: therapeutic implications for complex diseases. Inflammopharmacology. 2025;33:1583\u2013616.","journal-title":"Inflammopharmacology"},{"key":"7012_CR42","doi-asserted-by":"publisher","first-page":"1548073","DOI":"10.3389\/fphar.2025.1548073","volume":"16","author":"J Cui","year":"2025","unstructured":"Cui J, Li H, Zhang T, Lin F, Chen M, Zhang G, et al. Research progress on the mechanism of curcumin anti-oxidative stress based on signaling pathway. Front Pharm. 2025;16:1548073.","journal-title":"Front Pharm"},{"key":"7012_CR43","doi-asserted-by":"publisher","first-page":"625","DOI":"10.5152\/tjg.2024.23526","volume":"35","author":"X Zheng","year":"2025","unstructured":"Zheng X, Liu J, Hu W, Jiang B, Zhou X, Zhang M, et al. Curcumin induces autophagy-mediated ferroptosis by targeting the PI3K\/AKT\/mTOR signaling pathway in gastric cancer. Turk J Gastroenterol. 2025;35:625\u201333.","journal-title":"Turk J Gastroenterol"},{"key":"7012_CR44","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/1759-7714.13904","volume":"12","author":"X Tang","year":"2021","unstructured":"Tang X, Ding H, Liang M, Chen X, Yan Y, Wan N, et al. Curcumin induces ferroptosis in non-small-cell lung cancer via activating autophagy. Thorac Cancer. 2021;12:1219\u201330.","journal-title":"Thorac Cancer"},{"key":"7012_CR45","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1177\/15353702231220670","volume":"248","author":"C Yuan","year":"2023","unstructured":"Yuan C, Fan R, Zhu K, Wang Y, Xie W, Liang Y. Curcumin induces ferroptosis and apoptosis in osteosarcoma cells by regulating Nrf2\/GPX4 signaling pathway. Exp Biol Med. 2023;248:2183\u201397.","journal-title":"Exp Biol Med"},{"key":"7012_CR46","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00432-024-05878-0","volume":"150","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Hui D, Pan Z, Yu Y, Liu L, Yu X, et al. Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4. J Cancer Res Clin Oncol. 2024;150:429.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7012_CR47","doi-asserted-by":"publisher","first-page":"e107514","DOI":"10.1371\/journal.pone.0107514","volume":"9","author":"C Buhrmann","year":"2014","unstructured":"Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M. Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT. PLoS ONE. 2014;9:e107514.","journal-title":"PLoS ONE"},{"key":"7012_CR48","doi-asserted-by":"publisher","first-page":"934534","DOI":"10.3389\/fphar.2022.934534","volume":"13","author":"DL Pouliquen","year":"2022","unstructured":"Pouliquen DL, Boissard A, Henry C, Coqueret O, Guette C. Curcuminoids as modulators of EMT in invasive cancers: a review of molecular targets with the contribution of malignant mesothelioma studies. Front Pharm. 2022;13:934534.","journal-title":"Front Pharm"},{"key":"7012_CR49","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3390\/cancers13061335","volume":"13","author":"C K\u00f6tting","year":"2021","unstructured":"K\u00f6tting C, Hofmann L, Lotfi R, Engelhardt D, Laban S, Schuler PJ, et al. Immune-stimulatory effects of curcumin on the tumor microenvironment in head and neck squamous cell carcinoma. Cancers. 2021;13:1335.","journal-title":"Cancers"},{"key":"7012_CR50","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1002\/mnfr.201200609","volume":"57","author":"GD Noratto","year":"2013","unstructured":"Noratto GD, Jutooru I, Safe S, Angel-Morales G, Mertens-Talcott SU. The drug resistance suppression induced by curcuminoids in colon cancer SW-480 cells is mediated by reactive oxygen species-induced disruption of the microRNA-27a-ZBTB10-Sp axis. Mol Nutr Food Res. 2013;57:1638\u201348.","journal-title":"Mol Nutr Food Res"},{"key":"7012_CR51","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1021\/acs.jafc.8b06665","volume":"67","author":"X La","year":"2019","unstructured":"La X, Zhang L, Li Z, Li H, Yang Y. (-)-Epigallocatechin Gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5-FU by inhibiting GRP78\/NF-\u03baB\/miR-155-5p\/MDR1 pathway. J Agric Food Chem. 2019;67:2510\u20138.","journal-title":"J Agric Food Chem"},{"key":"7012_CR52","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1002\/ptr.6694","volume":"34","author":"T Xu","year":"2020","unstructured":"Xu T, Guo P, He Y, Pi C, Wang Y, Feng X, et al. Application of curcumin and its derivatives in tumor multidrug resistance. Phytother Res. 2020;34:2438\u201358.","journal-title":"Phytother Res"},{"key":"7012_CR53","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3390\/antiox13070815","volume":"13","author":"KW Hon","year":"2024","unstructured":"Hon KW, Naidu R. Synergistic mechanisms of selected polyphenols in overcoming chemoresistance and enhancing chemosensitivity in colorectal cancer. Antioxidants. 2024;13:815.","journal-title":"Antioxidants"},{"key":"7012_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","volume":"59","author":"M Elmeliegy","year":"2020","unstructured":"Elmeliegy M, Vourvahis M, Guo C, Wang DD. Effect of P-glycoprotein (P-gp) inducers on exposure of P-gp substrates: review of clinical drug-drug interaction studies. Clin Pharmacokinet. 2020;59:699\u2013714.","journal-title":"Clin Pharmacokinet"},{"key":"7012_CR55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3892\/mmr.2012.1106","volume":"7","author":"D Xu","year":"2013","unstructured":"Xu D, Tian W, Shen H. P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent. Mol Med Rep. 2013;7:115\u201321.","journal-title":"Mol Med Rep"},{"key":"7012_CR56","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3727\/096504015X14452563486011","volume":"23","author":"X Zhou","year":"2016","unstructured":"Zhou X, Wang W, Li P, Zheng Z, Tu Y, Zhang Y, et al. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in inducing gastric cancer cell apoptosis both in vitro and in vivo. Oncol Res. 2016;23:29\u201334.","journal-title":"Oncol Res"},{"key":"7012_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fgene.2019.00514","volume":"10","author":"FU Hassan","year":"2019","unstructured":"Hassan FU, Rehman MS, Khan MS, Ali MA, Javed A, Nawaz A, et al. Curcumin as an alternative epigenetic modulator: mechanism of action and potential effects. Front Genet. 2019;10:514.","journal-title":"Front Genet"},{"key":"7012_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s40203-024-00221-4","volume":"12","author":"A Anandaradje","year":"2024","unstructured":"Anandaradje A, Kalita B, Coumar MS, Selvarajan S. Molecular docking of curcumin and curcuminoids as human Zn(+) dependent histone deacetylase (HDAC) enzyme inhibitors. Silico Pharm. 2024;12:47.","journal-title":"Silico Pharm"},{"key":"7012_CR59","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3390\/nu13020332","volume":"13","author":"K Fabianowska-Majewska","year":"2021","unstructured":"Fabianowska-Majewska K, Kaufman-Szymczyk A, Szymanska-Kolba A, Jakubik J, Majewski G, Lubecka K. Curcumin from turmeric rhizome: a potential modulator of DNA methylation machinery in breast cancer inhibition. Nutrients. 2021;13:332.","journal-title":"Nutrients"},{"key":"7012_CR60","doi-asserted-by":"publisher","first-page":"14293","DOI":"10.3390\/molecules200814293","volume":"20","author":"X Chen","year":"2015","unstructured":"Chen X, Zou LQ, Niu J, Liu W, Peng SF, Liu CM. The stability, sustained release and cellular antioxidant activity of curcumin nanoliposomes. Molecules. 2015;20:14293\u2013311.","journal-title":"Molecules"},{"key":"7012_CR61","doi-asserted-by":"publisher","first-page":"e16850","DOI":"10.1016\/j.heliyon.2023.e16850","volume":"9","author":"D Vadivel","year":"2023","unstructured":"Vadivel D, Zitarosa N, Dondi D. Influence of pH on the release of an active principle from 3D printed carrageenan-k combined with alginate or xanthan gum. Heliyon. 2023;9:e16850.","journal-title":"Heliyon"},{"key":"7012_CR62","doi-asserted-by":"publisher","first-page":"292760","DOI":"10.1155\/2010\/292760","volume":"2010","author":"B Zebib","year":"2010","unstructured":"Zebib B, Mouloungui Z, Noirot V. Stabilization of curcumin by complexation with divalent cations in glycerol\/water system. Bioinorg Chem Appl. 2010;2010:292760.","journal-title":"Bioinorg Chem Appl"},{"key":"7012_CR63","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.3390\/ijms21249435","volume":"21","author":"BC Walker","year":"2020","unstructured":"Walker BC, Mittal S. Antitumor activity of curcumin in glioblastoma. Int J Mol Sci. 2020;21:9435.","journal-title":"Int J Mol Sci"},{"key":"7012_CR64","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acs.jpca.3c05933","volume":"128","author":"P Chatterjee","year":"2024","unstructured":"Chatterjee P, Dutta SS, Agarwal M, Dey S, Chakraborty T. UV-A-induced photoisomerization and photodimerization of curcumin: an ion mobility mass spectrometry study. J Phys Chem A. 2024;128:548\u201362.","journal-title":"J Phys Chem A"},{"key":"7012_CR65","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3390\/molecules25061397","volume":"25","author":"SJ Stohs","year":"2020","unstructured":"Stohs SJ, Chen O, Ray SD, Ji J, Bucci LR, Preuss HG. Highly bioavailable forms of curcumin and promising avenues for curcumin-based research and application: a review. Molecules. 2020;25:1397.","journal-title":"Molecules"},{"key":"7012_CR66","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3390\/molecules24162930","volume":"24","author":"RR Kotha","year":"2019","unstructured":"Kotha RR, Luthria DL. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules. 2019;24:2930.","journal-title":"Molecules"},{"key":"7012_CR67","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807\u201318.","journal-title":"Mol Pharm"},{"key":"7012_CR68","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2147\/DDDT.S320119","volume":"15","author":"W Hong","year":"2021","unstructured":"Hong W, Guo F, Yu N, Ying S, Lou B, Wu J, et al. A novel folic acid receptor-targeted drug delivery system based on curcumin-loaded \u03b2-cyclodextrin nanoparticles for cancer treatment. Drug Des Dev Ther. 2021;15:2843\u201355.","journal-title":"Drug Des Dev Ther"},{"key":"7012_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-11-37","volume":"11","author":"MH Ucisik","year":"2013","unstructured":"Ucisik MH, K\u00fcpc\u00fc S, Schuster B, Sleytr UB. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin. J Nanobiotechnology. 2013;11:37.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR70","doi-asserted-by":"publisher","first-page":"3667","DOI":"10.2147\/IJN.S30428","volume":"7","author":"W Wang","year":"2012","unstructured":"Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K, et al. Enhanced bioavailability and efficiency of curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomed. 2012;7:3667\u201377.","journal-title":"Int J Nanomed"},{"key":"7012_CR71","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00432-020-03432-2","volume":"147","author":"P Sminia","year":"2021","unstructured":"Sminia P, van den Berg J, van Kootwijk A, Hageman E, Slotman BJ, Verbakel W. Experimental and clinical studies on radiation and curcumin in human glioma. J Cancer Res Clin Oncol. 2021;147:403\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7012_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-491","volume":"10","author":"C Senft","year":"2010","unstructured":"Senft C, Polacin M, Priester M, Seifert V, K\u00f6gel D, Weissenberger J. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer. 2010;10:491.","journal-title":"BMC Cancer"},{"key":"7012_CR73","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01668-9","volume":"21","author":"X Qi","year":"2022","unstructured":"Qi X, Jha SK, Jha NK, Dewanjee S, Dey A, Deka R, et al. Antioxidants in brain tumors: current therapeutic significance and future prospects. Mol Cancer. 2022;21:204.","journal-title":"Mol Cancer"},{"key":"7012_CR74","doi-asserted-by":"publisher","first-page":"e37903","DOI":"10.1097\/MD.0000000000037903","volume":"103","author":"CA Philips","year":"2024","unstructured":"Philips CA, Theruvath AH. A comprehensive review on the hepatotoxicity of herbs used in the Indian (Ayush) systems of alternative medicine. Medicine. 2024;103:e37903.","journal-title":"Medicine"},{"key":"7012_CR75","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bcp.14460","volume":"87","author":"N Lombardi","year":"2021","unstructured":"Lombardi N, Crescioli G, Maggini V, Ippoliti I, Menniti-Ippolito F, Gallo E, et al. Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports. Br J Clin Pharm. 2021;87:741\u201353.","journal-title":"Br J Clin Pharm"},{"key":"7012_CR76","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","volume":"17","author":"Q Lu","year":"2024","unstructured":"Lu Q, Kou D, Lou S, Ashrafizadeh M, Aref AR, Canadas I, et al. Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol. 2024;17:16.","journal-title":"J Hematol Oncol"},{"key":"7012_CR77","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.phrs.2018.03.013","volume":"132","author":"D Pastorelli","year":"2018","unstructured":"Pastorelli D, Fabricio A, Giovanis P, D'Ippolito S, Fiduccia P, Sold\u00e0 C, et al. Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: results of a prospective phase II trial. Pharm Res. 2018;132:72\u20139.","journal-title":"Pharm Res"},{"key":"7012_CR78","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.2147\/IJN.S459710","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, Deng T, Liu X, Fang X, Mo Y, Xie N, et al. Smart nanoplatforms responding to the tumor microenvironment for precise drug delivery in cancer therapy. Int J Nanomed. 2024;19:6253\u201377.","journal-title":"Int J Nanomed"},{"key":"7012_CR79","doi-asserted-by":"publisher","first-page":"e12829","DOI":"10.1016\/j.heliyon.2023.e12829","volume":"9","author":"C Wang","year":"2023","unstructured":"Wang C, Jiang X, Zhang X, Xu Y, Li L, Li X, et al. A novel solvent-free co-grinding preparation improves curcumin bioavailability in healthy volunteers: a single-center crossover study. Heliyon. 2023;9:e12829.","journal-title":"Heliyon"},{"key":"7012_CR80","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.2147\/IJN.S118568","volume":"11","author":"Y Gu","year":"2016","unstructured":"Gu Y, Li J, Li Y, Song L, Li D, Peng L, et al. Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer. Int J Nanomed. 2016;11:5757\u201370.","journal-title":"Int J Nanomed"},{"key":"7012_CR81","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.3390\/molecules25122791","volume":"25","author":"B Zheng","year":"2020","unstructured":"Zheng B, McClements DJ. Formulation of more efficacious curcumin delivery systems using colloid science: enhanced solubility, stability, and bioavailability. Molecules. 2020;25:2791.","journal-title":"Molecules"},{"key":"7012_CR82","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.3390\/molecules17055972","volume":"17","author":"Y Chen","year":"2012","unstructured":"Chen Y, Wu Q, Zhang Z, Yuan L, Liu X, Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules. 2012;17:5972\u201387.","journal-title":"Molecules"},{"key":"7012_CR83","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/polym12092167","volume":"12","author":"NZ Nagy","year":"2020","unstructured":"Nagy NZ, Varga Z, Mih\u00e1ly J, Domj\u00e1n A, Fenyvesi \u00c9, Kiss \u00c9. Highly enhanced curcumin delivery applying association type nanostructures of block copolymers, cyclodextrins and polycyclodextrins. Polymers. 2020;12:2167.","journal-title":"Polymers"},{"key":"7012_CR84","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.nano.2011.07.011","volume":"8","author":"SS Dhule","year":"2012","unstructured":"Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, et al. Curcumin-loaded \u03b3-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine. 2012;8:440\u201351.","journal-title":"Nanomedicine"},{"key":"7012_CR85","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/pharmaceutics15020382","volume":"15","author":"L Nikoli\u0107","year":"2023","unstructured":"Nikoli\u0107 L, Uro\u0161evi\u0107 M, Nikoli\u0107 V, Gaji\u0107 I, Dini\u0107 A, Miljkovi\u0107 V, et al. The formulation of curcumin: 2-hydroxypropyl-\u03b2-cyclodextrin complex with smart hydrogel for prolonged release of curcumin. Pharmaceutics. 2023;15:382.","journal-title":"Pharmaceutics"},{"key":"7012_CR86","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev. 2016;99:28\u201351.","journal-title":"Adv Drug Deliv Rev"},{"key":"7012_CR87","doi-asserted-by":"publisher","first-page":"1700147.","DOI":"10.1002\/smtd.201700147","volume":"1","author":"J Zhuang","year":"2017","unstructured":"Zhuang J, Fang RH, Zhang L. Preparation of particulate polymeric therapeutics for medical applications. Small Methods. 2017;1:1700147.","journal-title":"Small Methods"},{"key":"7012_CR88","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1021\/bc300608h","volume":"24","author":"X Zhang","year":"2013","unstructured":"Zhang X, Lu J, Huang Y, Zhao W, Chen Y, Li J, et al. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel. Bioconjug Chem. 2013;24:464\u201372.","journal-title":"Bioconjug Chem"},{"key":"7012_CR89","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/molecules23040739","volume":"23","author":"V De Leo","year":"2018","unstructured":"De Leo V, Milano F, Mancini E, Comparelli R, Giotta L, Nacci A, et al. Encapsulation of curcumin-loaded liposomes for colonic drug delivery in a pH-responsive polymer cluster using a pH-driven and organic solvent-free process. Molecules. 2018;23:739.","journal-title":"Molecules"},{"key":"7012_CR90","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/10717544.2022.2083724","volume":"29","author":"A Salawi","year":"2022","unstructured":"Salawi A. Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv. 2022;29:1811\u201323.","journal-title":"Drug Deliv"},{"key":"7012_CR91","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.2147\/IJN.S408115","volume":"18","author":"L Lin","year":"2023","unstructured":"Lin L, Chen Q, Dai Y, Xia Y. Self-nanoemulsifying drug delivery system for enhanced bioavailability of madecassic acid: in vitro and in vivo evaluation. Int J Nanomed. 2023;18:2345\u201358.","journal-title":"Int J Nanomed"},{"key":"7012_CR92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/10717544.2010.520353","volume":"18","author":"Y Gao","year":"2011","unstructured":"Gao Y, Li Z, Sun M, Guo C, Yu A, Xi Y, et al. Preparation and characterization of intravenously injectable curcumin nanosuspension. Drug Deliv. 2011;18:131\u201342.","journal-title":"Drug Deliv"},{"key":"7012_CR93","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/bioengineering5010016","volume":"5","author":"BD Kevadiya","year":"2018","unstructured":"Kevadiya BD, Barvaliya M, Zhang L, Anovadiya A, Brahmbhatt H, Paul P, et al. Fenofibrate Nanocrystals embedded in oral strip-films for bioavailability enhancement. Bioengineering. 2018;5:16.","journal-title":"Bioengineering"},{"key":"7012_CR94","doi-asserted-by":"publisher","first-page":"5236","DOI":"10.3390\/molecules27165236","volume":"27","author":"S Hafez Ghoran","year":"2022","unstructured":"Hafez Ghoran S, Calcaterra A, Abbasi M, Taktaz F, Nieselt K, Babaei E. Curcumin-based nanoformulations: a promising adjuvant towards cancer treatment. Molecules. 2022;27:5236.","journal-title":"Molecules"},{"key":"7012_CR95","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","volume":"15","author":"SC Gupta","year":"2013","unstructured":"Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15:195\u2013218.","journal-title":"AAPS J"},{"key":"7012_CR96","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/17425247.2025.2479759","volume":"22","author":"F Laffleur","year":"2025","unstructured":"Laffleur F, Millotti G, Lagast J. An overview of oral bioavailability enhancement through self-emulsifying drug delivery systems. Expert Opin Drug Deliv. 2025;22:659\u201371.","journal-title":"Expert Opin Drug Deliv"},{"key":"7012_CR97","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11130-021-00929-0","volume":"76","author":"CM Gonzales","year":"2021","unstructured":"Gonzales CM, Dalmolin LF, da Silva KA, Slade N, Lopez R, Moreto JA, et al. New insights of turmeric extract-loaded PLGA nanoparticles: development, characterization and in vitro evaluation of antioxidant activity. Plant Foods Hum Nutr. 2021;76:507\u201315.","journal-title":"Plant Foods Hum Nutr"},{"key":"7012_CR98","first-page":"549","volume":"19","author":"YSM Elmahboub","year":"2024","unstructured":"Elmahboub YSM, Elkordy AA. Polymeric nanoparticles: a promising strategy for treatment of Alzheimer\u2019s disease. J Taibah Univ Med Sci. 2024;19:549\u201365.","journal-title":"J Taibah Univ Med Sci"},{"key":"7012_CR99","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.2147\/DDDT.S211748","volume":"13","author":"XP Chen","year":"2019","unstructured":"Chen XP, Li Y, Zhang Y, Li GW. Formulation, characterization and evaluation of curcumin- loaded PLGA- TPGS nanoparticles for liver cancer treatment. Drug Des Dev Ther. 2019;13:3569\u201378.","journal-title":"Drug Des Dev Ther"},{"key":"7012_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3831\/KPI.2024.27.1.1","volume":"27","author":"A Samadder","year":"2024","unstructured":"Samadder A, Bhattacharjee B, Dey S, Chakrovorty A, Dey R, Sow P, et al. Enhanced drug carriage efficiency of curcumin-loaded PLGA nanoparticles in combating diabetic nephropathy via mitigation of renal apoptosis. J Pharmacopunct. 2024;27:1\u201313.","journal-title":"J Pharmacopunct"},{"key":"7012_CR101","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.colsurfb.2014.01.007","volume":"116","author":"LH Chuah","year":"2014","unstructured":"Chuah LH, Roberts CJ, Billa N, Abdullah S, Rosli R. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles. Colloids Surf B Biointerfaces. 2014;116:228\u201336.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"7012_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/252531","volume":"2013","author":"M Malhotra","year":"2013","unstructured":"Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S. Systemic siRNA delivery via peptide-tagged polymeric nanoparticles, targeting PLK1 gene in a mouse xenograft model of colorectal cancer. Int J Biomater. 2013;2013:1\u201313.","journal-title":"Int J Biomater"},{"key":"7012_CR103","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.3390\/pharmaceutics13091420","volume":"13","author":"SC Pillai","year":"2021","unstructured":"Pillai SC, Borah A, Le M, Kawano H, Hasegawa K, Kumar DS. Co-delivery of curcumin and bioperine via PLGA nanoparticles to prevent atherosclerotic foam cell formation. Pharmaceutics. 2021;13:1420.","journal-title":"Pharmaceutics"},{"key":"7012_CR104","doi-asserted-by":"publisher","first-page":"1030936","DOI":"10.3389\/fbioe.2022.1030936","volume":"10","author":"MM El-Sherbiny","year":"2022","unstructured":"El-Sherbiny MM, Elekhtiar RS, El-Hefnawy ME, Mahrous H, Alhayyani S, Al-Goul ST, et al. Fabrication and assessment of potent anticancer nanoconjugates from chitosan nanoparticles, curcumin, and eugenol. Front Bioeng Biotechnol. 2022;10:1030936.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR105","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms25020786","volume":"25","author":"M Jamro\u017cy","year":"2024","unstructured":"Jamro\u017cy M, Kud\u0142acik-Kramarczyk S, Drabczyk A, Krzan M. Advanced drug carriers: a review of selected protein, polysaccharide, and lipid drug delivery platforms. Int J Mol Sci. 2024;25:786.","journal-title":"Int J Mol Sci"},{"key":"7012_CR106","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3390\/nano9040638","volume":"9","author":"B Garc\u00eda-Pinel","year":"2019","unstructured":"Garc\u00eda-Pinel B, Porras-Alcal\u00e1 C, Ortega-Rodr\u00edguez A, Sarabia F, Prados J, Melguizo C, et al. Lipid-based nanoparticles: application and recent advances in cancer treatment. Nanomaterials. 2019;9:638.","journal-title":"Nanomaterials"},{"key":"7012_CR107","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/pharmaceutics16101270","volume":"16","author":"DA Safta","year":"2024","unstructured":"Safta DA, Bogdan C, Moldovan ML. SLNs and NLCs for skin applications: enhancing the bioavailability of natural bioactives. Pharmaceutics. 2024;16:1270.","journal-title":"Pharmaceutics"},{"key":"7012_CR108","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.2147\/IJN.S36257","volume":"7","author":"M Fang","year":"2012","unstructured":"Fang M, Jin Y, Bao W, Gao H, Xu M, Wang D, et al. In vitro characterization and in vivo evaluation of nanostructured lipid curcumin carriers for intragastric administration. Int J Nanomed. 2012;7:5395\u2013404.","journal-title":"Int J Nanomed"},{"key":"7012_CR109","doi-asserted-by":"publisher","first-page":"125328","DOI":"10.1016\/j.foodchem.2019.125328","volume":"302","author":"C Ban","year":"2020","unstructured":"Ban C, Jo M, Park YH, Kim JH, Han JY, Lee KW, et al. Enhancing the oral bioavailability of curcumin using solid lipid nanoparticles. Food Chem. 2020;302:125328.","journal-title":"Food Chem"},{"key":"7012_CR110","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1080\/10717544.2017.1391890","volume":"24","author":"C Tian","year":"2017","unstructured":"Tian C, Asghar S, Wu Y, Kambere Amerigos D, Chen Z, Zhang M, et al. N-acetyl-L-cysteine functionalized nanostructured lipid carrier for improving oral bioavailability of curcumin: preparation, in vitro and in vivo evaluations. Drug Deliv. 2017;24:1605\u201316.","journal-title":"Drug Deliv"},{"key":"7012_CR111","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1007\/s13346-021-01095-1","volume":"13","author":"M Akanda","year":"2023","unstructured":"Akanda M, Getti G, Douroumis D. In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours. Drug Deliv Transl Res. 2023;13:2083\u201395.","journal-title":"Drug Deliv Transl Res"},{"key":"7012_CR112","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/nu11010068","volume":"11","author":"CY Hsu","year":"2019","unstructured":"Hsu CY, Wang PW, Alalaiwe A, Lin ZC, Fang JY. Use of lipid nanocarriers to improve oral delivery of vitamins. Nutrients. 2019;11:68.","journal-title":"Nutrients"},{"key":"7012_CR113","first-page":"2733","volume":"8","author":"A Ali Khan","year":"2013","unstructured":"Ali Khan A, Mudassir J, Mohtar N, Darwis Y. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations. Int J Nanomed. 2013;8:2733\u201344.","journal-title":"Int J Nanomed"},{"key":"7012_CR114","first-page":"289","volume":"2","author":"M Uner","year":"2007","unstructured":"Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed. 2007;2:289\u2013300.","journal-title":"Int J Nanomed"},{"key":"7012_CR115","doi-asserted-by":"publisher","first-page":"157652","DOI":"10.1016\/j.phymed.2025.157652","volume":"150","author":"X Zhang","year":"2026","unstructured":"Zhang X, Fei G, Xiujia S, Ganesan K, Chen J. Natural compound-nanoparticle therapies for breast cancer: a review from 2018-25. Phytomedicine. 2026;150:157652.","journal-title":"Phytomedicine"},{"key":"7012_CR116","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18:1606\u201314.","journal-title":"Mol Ther"},{"key":"7012_CR117","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/molecules25030689","volume":"25","author":"M Moballegh Nasery","year":"2020","unstructured":"Moballegh Nasery M, Abadi B, Poormoghadam D, Zarrabi A, Keyhanvar P, Khanbabaei H, et al. Curcumin delivery mediated by bio-based nanoparticles: a review. Molecules. 2020;25:689.","journal-title":"Molecules"},{"key":"7012_CR118","doi-asserted-by":"publisher","first-page":"751079","DOI":"10.3389\/fcell.2021.751079","volume":"9","author":"H Chen","year":"2021","unstructured":"Chen H, Wang L, Zeng X, Schwarz H, Nanda HS, Peng X. et al. Exosomes, a new star for targeted delivery. Front Cell Dev Biol. 2021;9:751079.","journal-title":"Front Cell Dev Biol"},{"key":"7012_CR119","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02452-1","volume":"22","author":"X Xue","year":"2024","unstructured":"Xue X, Wang X, Pang M, Yu L, Qian J, Li X, et al. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments. J Nanobiotechnology. 2024;22:196.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR120","doi-asserted-by":"publisher","first-page":"8175","DOI":"10.2147\/IJN.S472038","volume":"19","author":"M Qiu","year":"2024","unstructured":"Qiu M, Zou J, Yang Z, Yang D, Wang R, Guo H. Strategies for targeting peptide-modified exosomes and their applications in the lungs. Int J Nanomed. 2024;19:8175\u201388.","journal-title":"Int J Nanomed"},{"key":"7012_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02298-7","volume":"22","author":"Q Yang","year":"2024","unstructured":"Yang Q, Li S, Ou H, Zhang Y, Zhu G, Li S, et al. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. J Nanobiotechnology. 2024;22:41.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR122","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","volume":"8","author":"M Zhang","year":"2023","unstructured":"Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z, et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct Target Ther. 2023;8:124.","journal-title":"Signal Transduct Target Ther"},{"key":"7012_CR123","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.3390\/ijms24076349","volume":"24","author":"K Djayanti","year":"2023","unstructured":"Djayanti K, Maharjan P, Cho KH, Jeong S, Kim MS, Shin MC, et al. Mesoporous silica nanoparticles as a potential nanoplatform: therapeutic applications and considerations. Int J Mol Sci. 2023;24:6349.","journal-title":"Int J Mol Sci"},{"key":"7012_CR124","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/17425247.2019.1598375","volume":"16","author":"RR Castillo","year":"2019","unstructured":"Castillo RR, Lozano D, Gonz\u00e1lez B, Manzano M, Izquierdo-Barba I, Vallet-Reg\u00ed M. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update. Expert Opin Drug Deliv. 2019;16:415\u201339.","journal-title":"Expert Opin Drug Deliv"},{"key":"7012_CR125","doi-asserted-by":"publisher","first-page":"317","DOI":"10.34172\/apb.2023.035","volume":"13","author":"Z Mohebian","year":"2023","unstructured":"Mohebian Z, Babazadeh M, Zarghami N. In vitro efficacy of curcumin-loaded amine-functionalized mesoporous silica nanoparticles against MCF-7 breast cancer cells. Adv Pharm Bull. 2023;13:317\u201327.","journal-title":"Adv Pharm Bull"},{"key":"7012_CR126","first-page":"100116","volume":"4","author":"B Siddiqui","year":"2022","unstructured":"Siddiqui B, Rehman AU, Haq IU, Al-Dossary AA, Elaissari A, Ahmed N. Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications. Int J Pharm X. 2022;4:100116.","journal-title":"Int J Pharm X"},{"key":"7012_CR127","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/pharmaceutics10030118","volume":"10","author":"R Narayan","year":"2018","unstructured":"Narayan R, Nayak UY, Raichur AM, Garg S. Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances. Pharmaceutics. 2018;10:118.","journal-title":"Pharmaceutics"},{"key":"7012_CR128","doi-asserted-by":"publisher","first-page":"505605","DOI":"10.1088\/0957-4484\/27\/50\/505605","volume":"27","author":"SB Hartono","year":"2016","unstructured":"Hartono SB, Hadisoewignyo L, Yang Y, Meka AK, Antaresti, Yu C. Amine functionalized cubic mesoporous silica nanoparticles as an oral delivery system for curcumin bioavailability enhancement. Nanotechnology. 2016;27:505605.","journal-title":"Nanotechnology"},{"key":"7012_CR129","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1007\/s13346-024-01575-0","volume":"14","author":"AM P\u00e9rez-Moreno","year":"2024","unstructured":"P\u00e9rez-Moreno AM, Aranda CJ, Torres MJ, Mayorga C, Paris JL. Immunomodulatory potential of rapamycin-loaded mesoporous silica nanoparticles: pore size-dependent drug loading, release, and in vitro cellular responses. Drug Deliv Transl Res. 2024;14:3467\u201376.","journal-title":"Drug Deliv Transl Res"},{"key":"7012_CR130","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3390\/nano11113132","volume":"11","author":"TP Pivetta","year":"2021","unstructured":"Pivetta TP, Botteon C, Ribeiro PA, Marcato PD, Raposo M. Nanoparticle systems for cancer phototherapy: an overview. Nanomaterials. 2021;11:3132.","journal-title":"Nanomaterials"},{"key":"7012_CR131","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.3390\/ijms19124031","volume":"19","author":"B Kl\u0119bowski","year":"2018","unstructured":"Kl\u0119bowski B, Depciuch J, Parli\u0144ska-Wojtan M, Baran J. Applications of noble metal-based nanoparticles in medicine. Int J Mol Sci. 2018;19:4031.","journal-title":"Int J Mol Sci"},{"key":"7012_CR132","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3390\/ijms23042150","volume":"23","author":"SK Vemuri","year":"2022","unstructured":"Vemuri SK, Halder S, Banala RR, Rachamalla HK, Devraj VM, Mallarpu CS, et al. Modulatory effects of biosynthesized gold nanoparticles conjugated with curcumin and paclitaxel on tumorigenesis and metastatic pathways-in vitro and in vivo studies. Int J Mol Sci. 2022;23:2150.","journal-title":"Int J Mol Sci"},{"key":"7012_CR133","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s11671-024-04104-7","volume":"19","author":"P Yadav","year":"2024","unstructured":"Yadav P, Bandyopadhyay A, Sarkar K. Enhancement of gold-curcumin nanoparticle mediated radiation response for improved therapy in cervical cancer: a computational approach and predictive pathway analysis. Discov Nano. 2024;19:153.","journal-title":"Discov Nano"},{"key":"7012_CR134","doi-asserted-by":"publisher","first-page":"5823","DOI":"10.3390\/molecules26195823","volume":"26","author":"I Ielo","year":"2021","unstructured":"Ielo I, Rando G, Giacobello F, Sfameni S, Castellano A, Galletta M, et al. Synthesis, chemical-physical characterization, and biomedical applications of functional gold nanoparticles: a review. Molecules. 2021;26:5823.","journal-title":"Molecules"},{"key":"7012_CR135","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.3390\/ijms25084488","volume":"25","author":"S Pinho","year":"2024","unstructured":"Pinho S, Ferreira-Gon\u00e7alves T, Lopes J, Amaral MN, Viana AS, Coelho J, et al. A step forward for the treatment of localized prostate cancer using gold nanoparticles combined with laser irradiation. Int J Mol Sci. 2024;25:4488.","journal-title":"Int J Mol Sci"},{"key":"7012_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02550-0","volume":"22","author":"Y Gong","year":"2024","unstructured":"Gong Y, Hu X, Chen M, Wang J. Recent progress of iron-based nanomaterials in gene delivery and tumor gene therapy. J Nanobiotechnology. 2024;22:309.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02859-w","volume":"22","author":"X Meng","year":"2024","unstructured":"Meng X, Shen Y, Zhao H, Lu X, Wang Z, Zhao Y. Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review. J Nanobiotechnology. 2024;22:587.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR138","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1039\/D1CS00659B","volume":"51","author":"M Vallet-Reg\u00ed","year":"2022","unstructured":"Vallet-Reg\u00ed M, Sch\u00fcth F, Lozano D, Colilla M, Manzano M. Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?. Chem Soc Rev. 2022;51:5365\u2013451.","journal-title":"Chem Soc Rev"},{"key":"7012_CR139","doi-asserted-by":"publisher","first-page":"7547","DOI":"10.2147\/IJN.S471734","volume":"19","author":"W Ma","year":"2024","unstructured":"Ma W, Wang X, Zhang D, Mu X. Research progress of disulfide bond based tumor microenvironment targeted drug delivery system. Int J Nanomed. 2024;19:7547\u201366.","journal-title":"Int J Nanomed"},{"key":"7012_CR140","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/nano10091649","volume":"10","author":"BA Witika","year":"2020","unstructured":"Witika BA, Makoni PA, Matafwali SK, Chabalenge B, Mwila C, Kalungia AC, et al. Biocompatibility of biomaterials for nanoencapsulation: current approaches. Nanomaterials. 2020;10:1649.","journal-title":"Nanomaterials"},{"key":"7012_CR141","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/pharmaceutics12090837","volume":"12","author":"S Su","year":"2020","unstructured":"Su S. Recent advances in nanocarrier-assisted therapeutics delivery systems. Pharmaceutics. 2020;12:837.","journal-title":"Pharmaceutics"},{"key":"7012_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46904-4","volume":"13","author":"S Asadi","year":"2023","unstructured":"Asadi S, Madrakian T, Ahmadi M, Aguirre M\u00c1, Afkhami A, Uroomiye SS, et al. Aerosol assisted synthesis of a pH responsive curcumin anticancer drug nanocarrier using chitosan and alginate natural polymers. Sci Rep. 2023;13:19389.","journal-title":"Sci Rep"},{"key":"7012_CR143","doi-asserted-by":"publisher","first-page":"124566","DOI":"10.1016\/j.ijbiomac.2023.124566","volume":"241","author":"S Parvaneh","year":"2023","unstructured":"Parvaneh S, Pourmadadi M, Abdouss M, Pourmousavi SA, Yazdian F, Rahdar A, et al. Carboxymethyl cellulose\/starch\/reduced graphene oxide composite as a pH-sensitive nanocarrier for curcumin drug delivery. Int J Biol Macromol. 2023;241:124566.","journal-title":"Int J Biol Macromol"},{"key":"7012_CR144","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3390\/pharmaceutics15061631","volume":"15","author":"M Santhamoorthy","year":"2023","unstructured":"Santhamoorthy M, Ramkumar V, Thirupathi K, Gnanasekaran L, Karuppannan V, Phan T, et al. L-lysine functionalized mesoporous silica hybrid nanoparticles for pH-responsive delivery of curcumin. Pharmaceutics. 2023;15:1631.","journal-title":"Pharmaceutics"},{"key":"7012_CR145","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308632","volume":"11","author":"X Wu","year":"2024","unstructured":"Wu X, Zhou Z, Li K, Liu S. Nanomaterials-induced redox imbalance: challenged and opportunities for nanomaterials in cancer therapy. Adv Sci. 2024;11:e2308632.","journal-title":"Adv Sci"},{"key":"7012_CR146","doi-asserted-by":"publisher","first-page":"1115440.","DOI":"10.3389\/fchem.2023.1115440","volume":"11","author":"X Shi","year":"2023","unstructured":"Shi X, Tian Y, Zhai S, Liu Y, Chu S, Xiong Z. The progress of research on the application of redox nanomaterials in disease therapy. Front Chem. 2023;11:1115440.","journal-title":"Front Chem"},{"key":"7012_CR147","doi-asserted-by":"publisher","first-page":"2100540","DOI":"10.1002\/advs.202100540","volume":"8","author":"C Yu","year":"2021","unstructured":"Yu C, Li L, Hu P, Yang Y, Wei W, Deng X, et al. Recent advances in stimulus-responsive nanocarriers for gene therapy. Adv Sci. 2021;8:2100540.","journal-title":"Adv Sci"},{"key":"7012_CR148","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1021\/acsabm.4c01579","volume":"8","author":"S Basak","year":"2025","unstructured":"Basak S, Das TK. Zwitterionic, stimuli-responsive liposomes for curcumin drug delivery: enhancing M2 macrophage polarization and reducing oxidative stress through enzyme-specific and hyperthermia-triggered release. ACS Appl Bio Mater. 2025;8:726\u201340.","journal-title":"ACS Appl Bio Mater"},{"key":"7012_CR149","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/gels10070440","volume":"10","author":"R Solanki","year":"2024","unstructured":"Solanki R, Bhatia D. Stimulus-responsive hydrogels for targeted cancer therapy. Gels. 2024;10:440.","journal-title":"Gels"},{"key":"7012_CR150","doi-asserted-by":"publisher","first-page":"20230025","DOI":"10.1002\/EXP.20230025","volume":"4","author":"J Liu","year":"2024","unstructured":"Liu J, Zhou Y, Lyu Q, Yao X, Wang W. Targeted protein delivery based on stimuli-triggered nanomedicine. Exploration. 2024;4:20230025.","journal-title":"Exploration"},{"key":"7012_CR151","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/IJN.S432112","volume":"19","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Hu W, Guo M, Zhang X, Zhang Q, Peng F, et al. MMP-2 responsive peptide hydrogel-based nanoplatform for multimodal tumor therapy. Int J Nanomed. 2024;19:53\u201371.","journal-title":"Int J Nanomed"},{"key":"7012_CR152","doi-asserted-by":"publisher","first-page":"2000129","DOI":"10.1002\/adtp.202000129","volume":"3","author":"N Pacifici","year":"2020","unstructured":"Pacifici N, Bolandparvaz A, Lewis JS. Stimuli-responsive biomaterials for vaccines and immunotherapeutic applications. Adv Ther. 2020;3:2000129.","journal-title":"Adv Ther"},{"key":"7012_CR153","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/gels9070536","volume":"9","author":"M Santhamoorthy","year":"2023","unstructured":"Santhamoorthy M, Kim SC. Dual pH- and thermo-sensitive poly(N-isopropylacrylamide-co-allylamine) nanogels for curcumin delivery: swelling-deswelling behavior and phase transition mechanism. Gels. 2023;9:536.","journal-title":"Gels"},{"key":"7012_CR154","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103444","volume":"9","author":"J Zhang","year":"2022","unstructured":"Zhang J, Lin Y, Lin Z, Wei Q, Qian J, Ruan R, et al. Stimuli-responsive nanoparticles for controlled drug delivery in synergistic cancer immunotherapy. Adv Sci. 2022;9:e2103444.","journal-title":"Adv Sci"},{"key":"7012_CR155","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/03639045.2021.1934869","volume":"47","author":"N Qiu","year":"2021","unstructured":"Qiu N, Du X, Ji J, Zhai G. A review of stimuli-responsive polymeric micelles for tumor-targeted delivery of curcumin. Drug Dev Ind Pharm. 2021;47:839\u201356.","journal-title":"Drug Dev Ind Pharm"},{"key":"7012_CR156","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3762\/bjnano.15.89","volume":"15","author":"DR Setyawati","year":"2024","unstructured":"Setyawati DR, Sekaringtyas FC, Pratiwi RD, Rosyidah A, Azhar R, Gustini N, et al. Recent updates in applications of nanomedicine for the treatment of hepatic fibrosis. Beilstein J Nanotechnol. 2024;15:1105\u201316.","journal-title":"Beilstein J Nanotechnol"},{"key":"7012_CR157","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.1002\/mco2.643","volume":"5","author":"X Chen","year":"2024","unstructured":"Chen X, Wu D, Chen Z. Biomedical applications of stimuli-responsive nanomaterials. MedComm. 2024;5:e643.","journal-title":"MedComm"},{"key":"7012_CR158","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2174\/0929867325666180209143715","volume":"25","author":"PM Carron","year":"2018","unstructured":"Carron PM, Crowley A, O'Shea D, McCann M, Howe O, Hunt M, et al. Targeting the folate receptor: improving efficacy in inorganic medicinal chemistry. Curr Med Chem. 2018;25:2675\u2013708.","journal-title":"Curr Med Chem"},{"key":"7012_CR159","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00432-014-1767-3","volume":"141","author":"R Bazak","year":"2015","unstructured":"Bazak R, Houri M, El Achy S, Kamel S, Refaat T. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 2015;141:769\u201384.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7012_CR160","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/1566523214666141224095105","volume":"15","author":"D Xiang","year":"2015","unstructured":"Xiang D, Shigdar S, Qiao G, Zhou SF, Li Y, Wei MQ, et al. Aptamer-mediated cancer gene therapy. Curr Gene Ther. 2015;15:109\u201319.","journal-title":"Curr Gene Ther"},{"key":"7012_CR161","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.drudis.2016.12.009","volume":"22","author":"JM Wickens","year":"2017","unstructured":"Wickens JM, Alsaab HO, Kesharwani P, Bhise K, Amin M, Tekade RK, et al. Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discov Today. 2017;22:665\u201380.","journal-title":"Drug Discov Today"},{"key":"7012_CR162","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.2147\/IJN.S242490","volume":"15","author":"C Huang","year":"2020","unstructured":"Huang C, Chen F, Zhang L, Yang Y, Yang X, Pan W. 99mTc radiolabeled HA\/TPGS-based curcumin-loaded nanoparticle for breast cancer synergistic theranostics: design, in vitro and in vivo evaluation. Int J Nanomed. 2020;15:2987\u201398.","journal-title":"Int J Nanomed"},{"key":"7012_CR163","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2147\/IJN.S49882","volume":"9","author":"B Kumar","year":"2014","unstructured":"Kumar B, Yadav A, Hideg K, Kuppusamy P, Teknos TN, Kumar P. Curcumin and 5-fluorouracil-loaded, folate- and transferrin-decorated polymeric magnetic nanoformulation: a synergistic cancer therapeutic approach, accelerated by magnetic hyperthermia. Int J Nanomed. 2014;9:437\u201359.","journal-title":"Int J Nanomed"},{"key":"7012_CR164","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.mtbio.2023.100760","volume":"22","author":"X Xu","year":"2023","unstructured":"Xu X, Xu L, Wen C, Xia J, Zhang Y, Liang Y. Programming assembly of biomimetic exosomes: an emerging theranostic nanomedicine platform. Mater Today Bio. 2023;22:100760.","journal-title":"Mater Today Bio"},{"key":"7012_CR165","doi-asserted-by":"publisher","first-page":"1037741.","DOI":"10.3389\/fcvm.2022.1037741","volume":"9","author":"Y Gong","year":"2023","unstructured":"Gong Y, Liu H, Ke S, Zhuo L, Wang H. Latest advances in biomimetic nanomaterials for diagnosis and treatment of cardiovascular disease. Front Cardiovasc Med. 2023;9:1037741.","journal-title":"Front Cardiovasc Med"},{"key":"7012_CR166","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.3390\/nano10081556","volume":"10","author":"S Alven","year":"2020","unstructured":"Alven S, Aderibigbe BA. Efficacy of polymer-based nanocarriers for co-delivery of curcumin and selected anticancer drugs. Nanomaterials. 2020;10:1556.","journal-title":"Nanomaterials"},{"key":"7012_CR167","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3390\/ijms20051033","volume":"20","author":"MA Tomeh","year":"2019","unstructured":"Tomeh MA, Hadianamrei R, Zhao X. A review of curcumin and its derivatives as anticancer agents. Int J Mol Sci. 2019;20:1033.","journal-title":"Int J Mol Sci"},{"key":"7012_CR168","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.2147\/IJN.S72560","volume":"9","author":"J Qi","year":"2014","unstructured":"Qi J, Wu W, Wang K, Weng T, Tian Z, Lu Y, et al. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomed. 2014;9:4991\u20139.","journal-title":"Int J Nanomed"},{"key":"7012_CR169","doi-asserted-by":"publisher","first-page":"9961","DOI":"10.2147\/IJN.S276355","volume":"15","author":"AS Mohd Zaffarin","year":"2020","unstructured":"Mohd Zaffarin AS, Ng SF, Ng MH, Hassan H, Alias E. Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability. Int J Nanomed. 2020;15:9961\u201374.","journal-title":"Int J Nanomed"},{"key":"7012_CR170","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","volume":"371","author":"F Loupakis","year":"2014","unstructured":"Loupakis F, Cremolini C, Masi G, Lonardi S, Zagonel V, Salvatore L, et al. Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer. N Engl J Med. 2014;371:1609\u201318.","journal-title":"N Engl J Med"},{"key":"7012_CR171","doi-asserted-by":"publisher","first-page":"153473542211054","DOI":"10.1177\/15347354221105498","volume":"21","author":"Y Jeon","year":"2022","unstructured":"Jeon Y, Sym SJ, Yoo BK, Baek JH. Long-term survival, tolerability, and safety of first-line bevacizumab and FOLFIRI in combination with ginsenoside-modified nanostructured lipid carrier containing curcumin in patients with unresectable metastatic colorectal cancer. Integr Cancer Ther. 2022;21:15347354221105498.","journal-title":"Integr Cancer Ther"},{"key":"7012_CR172","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/jn\/nxz029","volume":"149","author":"LM Howells","year":"2019","unstructured":"Howells LM, Iwuji C, Irving G, Barber S, Walter H, Sidat Z, et al. Curcumin combined with FOLFOX chemotherapy is safe and tolerable in patients with metastatic colorectal cancer in a randomized phase IIa trial. J Nutr. 2019;149:1133\u20139.","journal-title":"J Nutr"},{"key":"7012_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-020-00595-5","volume":"18","author":"F Guo","year":"2020","unstructured":"Guo F, Fu Q, Zhou K, Jin C, Wu W, Ji X, et al. Matrix metalloprotein-triggered, cell penetrating peptide-modified star-shaped nanoparticles for tumor targeting and cancer therapy. J Nanobiotechnology. 2020;18:48.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR174","doi-asserted-by":"publisher","first-page":"2202672","DOI":"10.1002\/adhm.202202672","volume":"12","author":"C Tramontano","year":"2023","unstructured":"Tramontano C, Martins JP, De Stefano L, Kemell M, Correia A, Terracciano M, et al. Microfluidic-assisted production of gastro-resistant active-targeted diatomite nanoparticles for the local release of galunisertib in metastatic colorectal cancer cells. Adv Health Mater. 2023;12:2202672.","journal-title":"Adv Health Mater"},{"key":"7012_CR175","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/pharmaceutics15030981","volume":"15","author":"F Casanova","year":"2023","unstructured":"Casanova F, Pereira CF, Ribeiro AB, Costa EM, Freixo R, Castro PM, et al. Design of innovative biocompatible cellulose nanostructures for the delivery and sustained release of curcumin. Pharmaceutics. 2023;15:981.","journal-title":"Pharmaceutics"},{"key":"7012_CR176","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-022-01586-4","volume":"20","author":"Y Guo","year":"2022","unstructured":"Guo Y, Wang M, Zou Y, Jin L, Zhao Z, Liu Q, et al. Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer. J Nanobiotechnology. 2022;20:371.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR177","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3390\/cancers13040898","volume":"13","author":"G Nabil","year":"2021","unstructured":"Nabil G, Alzhrani R, Alsaab HO, Atef M, Sau S, Iyer AK, et al. CD44 targeted nanomaterials for treatment of triple-negative breast cancer. Cancers. 2021;13:898.","journal-title":"Cancers"},{"key":"7012_CR178","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1021\/mp2000428","volume":"8","author":"HSS Qhattal","year":"2011","unstructured":"Qhattal HSS, Liu X. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes. Mol Pharm. 2011;8:1233\u201346.","journal-title":"Mol Pharm"},{"key":"7012_CR179","doi-asserted-by":"publisher","first-page":"800481","DOI":"10.3389\/fphar.2021.800481","volume":"12","author":"P Kesharwani","year":"2022","unstructured":"Kesharwani P, Chadar R, Sheikh A, Rizg WY, Safhi AY. CD44-Targeted Nanocarrier for Cancer Therapy. Front Pharmacol. 2022;12:800481.","journal-title":"Front Pharmacol"},{"key":"7012_CR180","doi-asserted-by":"publisher","first-page":"10950","DOI":"10.1021\/acs.chemrev.0c01338","volume":"121","author":"L Su","year":"2021","unstructured":"Su L, Feng Y, Wei K, Xu X, Liu R, Chen G. Carbohydrate-based macromolecular biomaterials. Chem Rev. 2021;121:10950\u20131029.","journal-title":"Chem Rev"},{"key":"7012_CR181","doi-asserted-by":"publisher","first-page":"612903","DOI":"10.3389\/fonc.2021.612903","volume":"11","author":"AS Ombredane","year":"2021","unstructured":"Ombredane AS, Silva VRP, Andrade LR, Pinheiro WO, Simonelly M, Oliveira JV, et al. In Vivo Efficacy and Toxicity of Curcumin Nanoparticles in Breast Cancer Treatment: A Systematic Review. Front Oncol. 2021;11:612903.","journal-title":"Front Oncol"},{"key":"7012_CR182","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1021\/nn405839n","volume":"8","author":"HS Qhattal","year":"2014","unstructured":"Qhattal HS, Hye T, Alali A, Liu X. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano. 2014;8:5423\u201340.","journal-title":"ACS Nano"},{"key":"7012_CR183","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.2147\/IJN.S132434","volume":"12","author":"T Feng","year":"2017","unstructured":"Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. Int J Nanomed. 2017;12:6027\u201344.","journal-title":"Int J Nanomed"},{"key":"7012_CR184","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/IJN.S95850","volume":"11","author":"NK Han","year":"2016","unstructured":"Han NK, Shin DH, Kim JS, Weon KY, Jang CY, Kim JS. Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells. Int J Nanomed. 2016;11:1413\u201325.","journal-title":"Int J Nanomed"},{"key":"7012_CR185","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.2147\/IJN.S200847","volume":"14","author":"Y Liu","year":"2019","unstructured":"Liu Y, Huang P, Hou X, Yan F, Jiang Z, Shi J, et al. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer. Int J Nanomed. 2019;14:3311\u201330.","journal-title":"Int J Nanomed"},{"key":"7012_CR186","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/ph15050542","volume":"15","author":"A Chaudhuri","year":"2022","unstructured":"Chaudhuri A, Kumar DN, Dehari D, Singh S, Kumar P, Bolla PK, et al. Emergence of nanotechnology as a powerful cavalry against triple-negative breast cancer (TNBC). Pharmaceuticals. 2022;15:542.","journal-title":"Pharmaceuticals"},{"key":"7012_CR187","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/pharmaceutics16020177","volume":"16","author":"D Dourado","year":"2024","unstructured":"Dourado D, Miranda JA, de Oliveira MC, Freire DT, Xavier-J\u00fanior FH, Paredes-Gamero EJ, et al. Recent trends in curcumin-containing inorganic-based nanoparticles intended for in vivo cancer therapy. Pharmaceutics. 2024;16:177.","journal-title":"Pharmaceutics"},{"key":"7012_CR188","doi-asserted-by":"publisher","first-page":"9023","DOI":"10.1039\/C7RA11667E","volume":"8","author":"S Zhao","year":"2018","unstructured":"Zhao S, Tian Y, Liu W, Su Y, Zhang Y, Teng Z, et al. High and low molecular weight hyaluronic acid-coated gold nanobipyramids for photothermal therapy. RSC Adv. 2018;8:9023\u201330.","journal-title":"RSC Adv"},{"key":"7012_CR189","first-page":"2895","volume":"21 4B","author":"AL Cheng","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21 4B:2895\u2013900.","journal-title":"Anticancer Res"},{"key":"7012_CR190","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1158\/1535-7163.MCT-10-0172","volume":"9","author":"S Bisht","year":"2010","unstructured":"Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010;9:2255\u201364.","journal-title":"Mol Cancer Ther"},{"key":"7012_CR191","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4251\/wjgo.v13.i4.231","volume":"13","author":"D Caputo","year":"2021","unstructured":"Caputo D, Pozzi D, Farolfi T, Passa R, Coppola R, Caracciolo G. Nanotechnology and pancreatic cancer management: State of the art and further perspectives. World J Gastrointest Oncol. 2021;13:231\u20137.","journal-title":"World J Gastrointest Oncol"},{"key":"7012_CR192","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1002\/ptr.7121","volume":"35","author":"M Bhatia","year":"2021","unstructured":"Bhatia M, Bhalerao M, Cruz-Martins N, Kumar D. Curcumin and cancer biology: focusing regulatory effects in different signalling pathways. Phytother Res. 2021;35:4913\u201329.","journal-title":"Phytother Res"},{"key":"7012_CR193","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.2147\/DDDT.S366558","volume":"16","author":"T Ma","year":"2022","unstructured":"Ma T, Jiang JL, Qi WX, Chen JY, Xu HP. A novel delivery system of RGD-HSA loaded GEM\/CUR nanoparticles for the treatment of pancreatic cancer therapy. Drug Des Dev Ther. 2022;16:2395\u2013406.","journal-title":"Drug Des Dev Ther"},{"key":"7012_CR194","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.2147\/IJN.S451151","volume":"19","author":"M Wang","year":"2024","unstructured":"Wang M, Xue W, Yuan H, Wang Z, Yu L. Nano-drug delivery systems targeting CAFs: a promising treatment for pancreatic cancer. Int J Nanomed. 2024;19:2823\u201349.","journal-title":"Int J Nanomed"},{"key":"7012_CR195","doi-asserted-by":"publisher","first-page":"e202414506","DOI":"10.1002\/anie.202414506","volume":"63","author":"C Zhang","year":"2024","unstructured":"Zhang C, Lin Z, Jiao L, Jiang HL. Metal-organic frameworks for electrocatalytic CO(2) reduction: from catalytic site design to microenvironment modulation. Angew Chem Int Ed Engl. 2024;63:e202414506.","journal-title":"Angew Chem Int Ed Engl"},{"key":"7012_CR196","doi-asserted-by":"publisher","first-page":"1248421","DOI":"10.3389\/fbioe.2023.1248421","volume":"11","author":"J Zheng","year":"2023","unstructured":"Zheng J, Jiang J, Pu Y, Xu T, Sun J, Zhang Q, et al. Tumor-associated macrophages in nanomaterial-based anti-tumor therapy: as target spots or delivery platforms. Front Bioeng Biotechnol. 2023;11:1248421.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR197","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.18632\/oncotarget.27109","volume":"10","author":"MS Strand","year":"2019","unstructured":"Strand MS, Krasnick BA, Pan H, Zhang X, Bi Y, Brooks C, et al. Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles. Oncotarget. 2019;10:4761\u201375.","journal-title":"Oncotarget"},{"key":"7012_CR198","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10555-025-10243-9","volume":"44","author":"Y Wang","year":"2025","unstructured":"Wang Y, Bui TA, Yang X, Hutvagner G, Deng W. Advancements in gene therapies targeting mutant KRAS in cancers. Cancer Metastasis Rev. 2025;44:24.","journal-title":"Cancer Metastasis Rev"},{"key":"7012_CR199","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.carbpol.2017.10.102","volume":"182","author":"P Yadav","year":"2018","unstructured":"Yadav P, Bandyopadhyay A, Chakraborty A, Sarkar K. Enhancement of anticancer activity and drug delivery of chitosan-curcumin nanoparticle via molecular docking and simulation analysis. Carbohydr Polym. 2018;182:188\u201398.","journal-title":"Carbohydr Polym"},{"key":"7012_CR200","doi-asserted-by":"publisher","first-page":"16933","DOI":"10.3390\/ijms242316933","volume":"24","author":"J Kim","year":"2023","unstructured":"Kim J. Nucleic acid-based approaches to tackle KRAS mutant cancers. Int J Mol Sci. 2023;24:16933.","journal-title":"Int J Mol Sci"},{"key":"7012_CR201","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/nu13030950","volume":"13","author":"SC Wong","year":"2021","unstructured":"Wong SC, Kamarudin MNA, Naidu R. Anticancer mechanism of curcumin on human glioblastoma. Nutrients. 2021;13:950.","journal-title":"Nutrients"},{"key":"7012_CR202","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2217\/nnm.13.35","volume":"9","author":"M Ghosh","year":"2014","unstructured":"Ghosh M, Ryan RO. ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells. Nanomedicine. 2014;9:763\u201371.","journal-title":"Nanomedicine"},{"key":"7012_CR203","first-page":"403","volume":"9","author":"M Tahmasebi Mirgani","year":"2014","unstructured":"Tahmasebi Mirgani M, Isacchi B, Sadeghizadeh M, Marra F, Bilia AR, Mowla SJ, et al. Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells. Int J Nanomed. 2014;9:403\u201317.","journal-title":"Int J Nanomed"},{"key":"7012_CR204","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"H Gao","year":"2016","unstructured":"Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016;6:268\u201386.","journal-title":"Acta Pharm Sin B"},{"key":"7012_CR205","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/antiox14030351","volume":"14","author":"A Nowacka","year":"2025","unstructured":"Nowacka A, Zi\u00f3\u0142kowska E, Smuczy\u0144ski W, Bo\u017ci\u0142ow D, \u015aniegocki M. Potential of curcumin and its analogs in glioblastoma therapy. Antioxidants. 2025;14:351.","journal-title":"Antioxidants"},{"key":"7012_CR206","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/ph17050612","volume":"17","author":"E Asimakidou","year":"2024","unstructured":"Asimakidou E, Tan J, Zeng J, Lo CH. Blood-brain barrier-targeting nanoparticles: biomaterial properties and biomedical applications in translational neuroscience. Pharmaceuticals. 2024;17:612.","journal-title":"Pharmaceuticals"},{"key":"7012_CR207","first-page":"609","volume":"6","author":"SL Brown","year":"2021","unstructured":"Brown SL, Snyder JM, Ali MM. Dendrimer-based nanomedicine (paramagnetic nanoparticle, nanocombretastatin, nanocurcumin) for glioblastoma multiforme imaging and therapy. Nov Approaches Cancer Study. 2021;6:609\u201314.","journal-title":"Nov Approaches Cancer Study"},{"key":"7012_CR208","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1002\/ijc.30398","volume":"139","author":"S Mukherjee","year":"2016","unstructured":"Mukherjee S, Baidoo J, Fried A, Atwi D, Dolai S, Boockvar J, et al. Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma. Int J Cancer. 2016;139:2838\u201349.","journal-title":"Int J Cancer"},{"key":"7012_CR209","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/ijms25052529","volume":"25","author":"E Obrador","year":"2024","unstructured":"Obrador E, Moreno-Murciano P, Oriol-Caballo M, L\u00f3pez-Blanch R, Pineda B, Guti\u00e9rrez-Arroyo JL, et al. Glioblastoma therapy: past, present and future. Int J Mol Sci. 2024;25:2529.","journal-title":"Int J Mol Sci"},{"key":"7012_CR210","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/pharmaceutics16050644","volume":"16","author":"H Omidian","year":"2024","unstructured":"Omidian H, Gill EJ, Cubeddu LX. Lipid nanoparticles in lung cancer therapy. Pharmaceutics. 2024;16:644.","journal-title":"Pharmaceutics"},{"key":"7012_CR211","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.3390\/molecules25194377","volume":"25","author":"A Mohanty","year":"2020","unstructured":"Mohanty A, Uthaman S, Park IK. Utilization of polymer-lipid hybrid nanoparticles for targeted anti-cancer therapy. Molecules. 2020;25:4377.","journal-title":"Molecules"},{"key":"7012_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01849-0","volume":"22","author":"KR Gajbhiye","year":"2023","unstructured":"Gajbhiye KR, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V. Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics. Mol Cancer. 2023;22:160.","journal-title":"Mol Cancer"},{"key":"7012_CR213","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/polym15030542","volume":"15","author":"MA Rahman","year":"2023","unstructured":"Rahman MA, Ali A, Rahamathulla M, Salam S, Hani U, Wahab S, et al. Fabrication of sustained release curcumin-loaded solid lipid nanoparticles (Cur-SLNs) as a potential drug delivery system for the treatment of lung cancer: optimization of formulation and in vitro biological evaluation. Polymers. 2023;15:542.","journal-title":"Polymers"},{"key":"7012_CR214","doi-asserted-by":"publisher","first-page":"110181","DOI":"10.1016\/j.biopha.2020.110181","volume":"127","author":"Y Chen","year":"2020","unstructured":"Chen Y, Deng Y, Zhu C, Xiang C. Anti prostate cancer therapy: aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Biomed Pharmacother. 2020;127:110181.","journal-title":"Biomed Pharmacother"},{"key":"7012_CR215","doi-asserted-by":"publisher","first-page":"e38409","DOI":"10.1016\/j.heliyon.2024.e38409","volume":"10","author":"S Kokkinis","year":"2024","unstructured":"Kokkinis S, Paudel KR, De Rubis G, Yeung S, Singh M, Singh SK, et al. Liposomal encapsulated curcumin attenuates lung cancer proliferation, migration, and induces apoptosis. Heliyon. 2024;10:e38409.","journal-title":"Heliyon"},{"key":"7012_CR216","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.2147\/DDDT.S311107","volume":"15","author":"Q Wu","year":"2021","unstructured":"Wu Q, Ou H, Shang Y, Zhang X, Wu J, Fan F. Nanoscale formulations: incorporating curcumin into combination strategies for the treatment of lung cancer. Drug Des Dev Ther. 2021;15:2695\u2013709.","journal-title":"Drug Des Dev Ther"},{"key":"7012_CR217","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1567201814666171019104002","volume":"15","author":"MN Khan","year":"2018","unstructured":"Khan MN, Haggag YA, Lane ME, McCarron PA, Tambuwala MM. Polymeric nano-encapsulation of curcumin enhances its anti-cancer activity in breast (MDA-MB231) and lung (A549) cancer cells through reduction in expression of HIF-1\u03b1 and nuclear p65 (Rel A). Curr Drug Deliv. 2018;15:286\u201395.","journal-title":"Curr Drug Deliv"},{"key":"7012_CR218","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/abbs\/gmt063","volume":"45","author":"H Yin","year":"2013","unstructured":"Yin H, Zhang H, Liu B. Superior anticancer efficacy of curcumin-loaded nanoparticles against lung cancer. Acta Biochim Biophys Sin. 2013;45:634\u201340.","journal-title":"Acta Biochim Biophys Sin"},{"key":"7012_CR219","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-01777-3","volume":"21","author":"Z Javed","year":"2021","unstructured":"Javed Z, Khan K, Rasheed A, Sadia H, Shahwani MN, Irshad A, et al. Targeting androgen receptor signaling with microRNAs and curcumin: a promising therapeutic approach for prostate cancer prevention and intervention. Cancer Cell Int. 2021;21:77.","journal-title":"Cancer Cell Int"},{"key":"7012_CR220","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.3390\/pharmaceutics14122770","volume":"14","author":"K AbouAitah","year":"2022","unstructured":"AbouAitah K, Soliman A, Swiderska-Sroda A, Nassrallah A, Smalc-Koziorowska J, Gierlotka S, et al. Co-delivery system of curcumin and colchicine using functionalized mesoporous silica nanoparticles promotes anticancer and apoptosis effects. Pharmaceutics. 2022;14:2770.","journal-title":"Pharmaceutics"},{"key":"7012_CR221","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/polym3031377","volume":"3","author":"HK Makadia","year":"2011","unstructured":"Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 2011;3:1377\u201397.","journal-title":"Polymers"},{"key":"7012_CR222","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/pharmaceutics14122728","volume":"14","author":"HO Alsaab","year":"2022","unstructured":"Alsaab HO, Alharbi FD, Alhibs AS, Alanazi NB, Alshehri BY, Saleh MA, et al. PLGA-based nanomedicine: history of advancement and development in clinical applications of multiple diseases. Pharmaceutics. 2022;14:2728.","journal-title":"Pharmaceutics"},{"key":"7012_CR223","first-page":"75047","volume":"16","author":"E Sarkar","year":"2024","unstructured":"Sarkar E, Khan A, Ahmad R, Misra A, Raza ST, Mahdi AA. Synergistic anticancer efficacy of curcumin and doxorubicin combination treatment inducing S-phase cell cycle arrest in triple-negative breast cancer cells: an in vitro study. Cureus. 2024;16:75047.","journal-title":"Cureus"},{"key":"7012_CR224","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.2147\/IJN.S401038","volume":"18","author":"J Zeng","year":"2023","unstructured":"Zeng J, Sun P, Fang X, Jiang Y, Wu Z, Qi X. \u201cShell-core\u201d bilayer nanoparticle as chemotherapeutic drug co-delivery platforms render synchronized microenvironment respond and enhanced antitumor effects. Int J Nanomed. 2023;18:1521\u201336.","journal-title":"Int J Nanomed"},{"key":"7012_CR225","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.3390\/molecules29173994","volume":"29","author":"H Yoo","year":"2024","unstructured":"Yoo H, Kim Y, Kim J, Cho H, Kim K. Overcoming cancer drug resistance with nanoparticle strategies for key protein inhibition. Molecules. 2024;29:3994.","journal-title":"Molecules"},{"key":"7012_CR226","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1080\/10717544.2021.1960926","volume":"28","author":"F Guo","year":"2021","unstructured":"Guo F, Yu N, Jiao Y, Hong W, Zhou K, Ji X, et al. Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Drug Deliv. 2021;28:1709\u201321.","journal-title":"Drug Deliv"},{"key":"7012_CR227","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/md21050314","volume":"21","author":"C Wang","year":"2023","unstructured":"Wang C, Zhang J, Wei X, Yang M, Ma W, Yu R, et al. Design, synthesis, and biological evaluation of marine lissodendrins B analogues as modulators of ABCB1-mediated multidrug resistance. Mar Drugs. 2023;21:314.","journal-title":"Mar Drugs"},{"key":"7012_CR228","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14518-x","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li K, Han X, Chen Q, Shao L, Bai D. A photochemical-responsive nanoparticle boosts doxorubicin uptake to suppress breast cancer cell proliferation by apoptosis. Sci Rep. 2022;12:10354.","journal-title":"Sci Rep"},{"key":"7012_CR229","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3892\/or.2017.5345","volume":"37","author":"T Cui","year":"2017","unstructured":"Cui T, Zhang S, Sun H. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Oncol Rep. 2017;37:1253\u201360.","journal-title":"Oncol Rep"},{"key":"7012_CR230","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-021-01134-6","volume":"19","author":"M Jia","year":"2021","unstructured":"Jia M, Zhang D, Zhang C, Li C. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy. J Nanobiotechnology. 2021;19:384.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR231","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1111\/cas.14675","volume":"111","author":"T Hayakawa","year":"2020","unstructured":"Hayakawa T, Yaguchi T, Kawakami Y. Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3. Cancer Sci. 2020;111:4326\u201335.","journal-title":"Cancer Sci"},{"key":"7012_CR232","doi-asserted-by":"publisher","first-page":"153758","DOI":"10.1016\/j.phymed.2021.153758","volume":"92","author":"L Liu","year":"2021","unstructured":"Liu L, Lim MA, Jung SN, Oh C, Won HR, Jin YL, et al. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer. Phytomedicine. 2021;92:153758.","journal-title":"Phytomedicine"},{"key":"7012_CR233","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-019-0473-3","volume":"17","author":"F Zhu","year":"2019","unstructured":"Zhu F, Tan G, Zhong Y, Jiang Y, Cai L, Yu Z, et al. Smart nanoplatform for sequential drug release and enhanced chemo-thermal effect of dual drug loaded gold nanorod vesicles for cancer therapy. J Nanobiotechnology. 2019;17:44.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR234","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.2147\/IJN.S363456","volume":"17","author":"Y Huang","year":"2022","unstructured":"Huang Y, Wang T, Yang J, Wu X, Fan W, Chen J. Current strategies for the treatment of hepatocellular carcinoma by modulating the tumor microenvironment via nano-delivery systems: a review. Int J Nanomed. 2022;17:2335\u201352.","journal-title":"Int J Nanomed"},{"key":"7012_CR235","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.7150\/jca.85966","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo L, Lin C, Wang P, Cao D, Lin Y, Wang W, et al. Combined use of immune checkpoint inhibitors and phytochemicals as a novel therapeutic strategy against cancer. J Cancer. 2023;14:2315\u201328.","journal-title":"J Cancer"},{"key":"7012_CR236","doi-asserted-by":"publisher","first-page":"1747688","DOI":"10.1080\/2162402X.2020.1747688","volume":"9","author":"Z Lv","year":"2020","unstructured":"Lv Z, Zhang P, Li D, Qin M, Nie L, Wang X, et al. CD19-targeting fusion protein combined with PD1 antibody enhances anti-tumor immunity in mouse models. Oncoimmunology. 2020;9:1747688.","journal-title":"Oncoimmunology"},{"key":"7012_CR237","first-page":"3059","volume":"19","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lu J, Jiang B, Guo J. The roles of curcumin in regulating the tumor immunosuppressive microenvironment. Oncol Lett. 2020;19:3059\u201370.","journal-title":"Oncol Lett"},{"key":"7012_CR238","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1080\/10717544.2022.2056662","volume":"29","author":"P Ji","year":"2022","unstructured":"Ji P, Wang X, Yin J, Mou Y, Huang H, Ren Z. Selective delivery of curcumin to breast cancer cells by self-targeting apoferritin nanocages with pH-responsive and low toxicity. Drug Deliv. 2022;29:986\u201396.","journal-title":"Drug Deliv"},{"key":"7012_CR239","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/pharmaceutics16010079","volume":"16","author":"J Zhu","year":"2024","unstructured":"Zhu J, Li Q, Wu Z, Xu Y, Jiang R. Curcumin for treating breast cancer: a review of molecular mechanisms, combinations with anticancer drugs, and nanosystems. Pharmaceutics. 2024;16:79.","journal-title":"Pharmaceutics"},{"key":"7012_CR240","doi-asserted-by":"publisher","first-page":"154344","DOI":"10.1016\/j.prp.2023.154344","volume":"243","author":"BZ Kandjani","year":"2023","unstructured":"Kandjani BZ, Hesari FS, Babaei E. Gemini curcumin inhibits 4T1 cancer cell proliferation and modulates the expression of apoptotic and metastatic genes in Balb\/c mice model. Pathol Res Pr. 2023;243:154344.","journal-title":"Pathol Res Pr"},{"key":"7012_CR241","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5414\/CP202076","volume":"53","author":"A Storka","year":"2015","unstructured":"Storka A, Vcelar B, Klickovic U, Gouya G, Weisshaar S, Aschauer S, et al. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans. Int J Clin Pharm Ther. 2015;53:54\u201365.","journal-title":"Int J Clin Pharm Ther"},{"key":"7012_CR242","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00262-022-03253-x","volume":"72","author":"EA De Jaeghere","year":"2023","unstructured":"De Jaeghere EA, Tuyaerts S, Van Nuffel A, Belmans A, Bogaerts K, Baiden-Amissah R, et al. Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: results of the phase II PRIMMO study. Cancer Immunol Immunother. 2023;72:475\u201391.","journal-title":"Cancer Immunol Immunother"},{"key":"7012_CR243","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.3390\/pharmaceutics14102239","volume":"14","author":"H Sun","year":"2022","unstructured":"Sun H, Zhan M, Mignani S, Shcharbin D, Majoral JP, Rodrigues J, et al. Modulation of macrophages using nanoformulations with curcumin to treat inflammatory diseases: a concise review. Pharmaceutics. 2022;14:2239.","journal-title":"Pharmaceutics"},{"key":"7012_CR244","doi-asserted-by":"publisher","first-page":"20839","DOI":"10.3390\/molecules191220839","volume":"19","author":"MH Teiten","year":"2014","unstructured":"Teiten MH, Dicato M, Diederich M. Hybrid curcumin compounds: a new strategy for cancer treatment. Molecules. 2014;19:20839\u201363.","journal-title":"Molecules"},{"key":"7012_CR245","doi-asserted-by":"publisher","first-page":"71","DOI":"10.61186\/ibj.4061","volume":"28","author":"SS Shah","year":"2024","unstructured":"Shah SS, Turakhia BP, Purohit N, Kapadiya KM, Sahoo CR, Prajapati A. Facile green synthesis of iron oxide nanoparticles and their impact on cytotoxicity, antioxidative properties and bactericidal activity. Iran Biomed J. 2024;28:71\u201381.","journal-title":"Iran Biomed J"},{"key":"7012_CR246","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.2147\/IJN.S484206","volume":"19","author":"C Yin","year":"2024","unstructured":"Yin C, Hu P, Qin L, Wang Z, Zhao H. The current status and future directions on nanoparticles for tumor molecular imaging. Int J Nanomed. 2024;19:9549\u201374.","journal-title":"Int J Nanomed"},{"key":"7012_CR247","first-page":"33","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Zhang B, Liu F, Luo J, Bai J. In vivo tomographic imaging with fluorescence and MRI using tumor-targeted dual-labeled nanoparticles. Int J Nanomed. 2014;9:33\u201341.","journal-title":"Int J Nanomed"},{"key":"7012_CR248","doi-asserted-by":"publisher","first-page":"4501","DOI":"10.1039\/C4CS00345D","volume":"44","author":"TH Shin","year":"2015","unstructured":"Shin TH, Choi Y, Kim S, Cheon J. Recent advances in magnetic nanoparticle-based multi-modal imaging. Chem Soc Rev. 2015;44:4501\u201316.","journal-title":"Chem Soc Rev"},{"key":"7012_CR249","first-page":"1","volume":"2022","author":"W Li","year":"2022","unstructured":"Li W, Sun Y, Chen J, Jiang Z, Yang J. PEGylated cisplatin nanoparticles for treating colorectal cancer in a pH-responsive manner. J Immunol Res. 2022;2022:1\u201311.","journal-title":"J Immunol Res"},{"key":"7012_CR250","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02158-w","volume":"21","author":"Y Fu","year":"2023","unstructured":"Fu Y, Sun J, Wang Y, Li W. Glucose oxidase and metal catalysts combined tumor synergistic therapy: mechanism, advance and nanodelivery system. J Nanobiotechnology. 2023;21:400.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR251","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1166\/jbn.2015.2145","volume":"11","author":"MDK Glasgow","year":"2015","unstructured":"Glasgow MDK, Chougule MB. Recent developments in active tumor targeted multifunctional nanoparticles for combination chemotherapy in cancer treatment and imaging. J Biomed Nanotechnol. 2015;11:1859\u201398.","journal-title":"J Biomed Nanotechnol"},{"key":"7012_CR252","doi-asserted-by":"publisher","first-page":"e202310061","DOI":"10.1002\/anie.202310061","volume":"62","author":"J Yang","year":"2023","unstructured":"Yang J, Yang B, Shi J. A nanomedicine-enabled ion-exchange strategy for enhancing curcumin-based rheumatoid arthritis therapy. Angew Chem Int Ed Engl. 2023;62:e202310061.","journal-title":"Angew Chem Int Ed Engl"},{"key":"7012_CR253","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","volume":"41","author":"N Kumari","year":"2022","unstructured":"Kumari N, Choi SH. Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies. J Exp Clin Cancer Res. 2022;41:68.","journal-title":"J Exp Clin Cancer Res"},{"key":"7012_CR254","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3390\/polym13172989","volume":"13","author":"Y Luengo Morato","year":"2021","unstructured":"Luengo Morato Y, Ovejero Paredes K, Lozano Chamizo L, Marciello M, Filice M. Recent advances in multimodal molecular imaging of cancer mediated by hybrid magnetic nanoparticles. Polymers. 2021;13:2989.","journal-title":"Polymers"},{"key":"7012_CR255","doi-asserted-by":"publisher","first-page":"16927","DOI":"10.1039\/D2RA01102F","volume":"12","author":"W Kang","year":"2022","unstructured":"Kang W, Tian Y, Zhao Y, Yin X, Teng Z. Applications of nanocomposites based on zeolitic imidazolate framework-8 in photodynamic and synergistic anti-tumor therapy. RSC Adv. 2022;12:16927\u201341.","journal-title":"RSC Adv"},{"key":"7012_CR256","doi-asserted-by":"publisher","first-page":"27180","DOI":"10.1039\/D3RA05176E","volume":"13","author":"LF Madeo","year":"2023","unstructured":"Madeo LF, Schirmer C, Cirillo G, Froeschke S, Hantusch M, Curcio M, et al. Facile one-pot hydrothermal synthesis of a zinc oxide\/curcumin nanocomposite with enhanced toxic activity against breast cancer cells. RSC Adv. 2023;13:27180\u20139.","journal-title":"RSC Adv"},{"key":"7012_CR257","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.3390\/molecules28207065","volume":"28","author":"X Zhang","year":"2023","unstructured":"Zhang X, Hu S, Huang L, Chen X, Wang X, Fu YN, et al. Advance progress in assembly mechanisms of carrier-free nanodrugs for cancer treatment. Molecules. 2023;28:7065.","journal-title":"Molecules"},{"key":"7012_CR258","doi-asserted-by":"publisher","first-page":"907","DOI":"10.3390\/nano8110907","volume":"8","author":"W Song","year":"2018","unstructured":"Song W, Su X, Gregory DA, Li W, Cai Z, Zhao X. Magnetic alginate\/chitosan nanoparticles for targeted delivery of curcumin into human breast cancer cells. Nanomaterials. 2018;8:907.","journal-title":"Nanomaterials"},{"key":"7012_CR259","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3390\/antiox13030331","volume":"13","author":"C Bertoncini-Silva","year":"2024","unstructured":"Bertoncini-Silva C, Vlad A, Ricciarelli R, Giacomo Fassini P, Suen V, Zingg JM. Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Antioxidants. 2024;13:331.","journal-title":"Antioxidants"},{"key":"7012_CR260","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.3390\/ma17143495","volume":"17","author":"M Shao","year":"2024","unstructured":"Shao M, Zhang W, Wang F, Wang L, Du H. A copper silicate-based multifunctional nanoplatform with glutathione depletion and hypoxia relief for synergistic photodynamic\/chemodynamic therapy. Materials. 2024;17:3495.","journal-title":"Materials"},{"key":"7012_CR261","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00280-018-3654-0","volume":"82","author":"R Greil","year":"2018","unstructured":"Greil R, Greil-Ressler S, Weiss L, Sch\u00f6nlieb C, Magnes T, Radl B, et al. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc(\u2122)) in patients with locally advanced or metastatic cancer. Cancer Chemother Pharm. 2018;82:695\u2013706.","journal-title":"Cancer Chemother Pharm"},{"key":"7012_CR262","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1002\/fsn3.2226","volume":"9","author":"R Ahmadi","year":"2021","unstructured":"Ahmadi R, Salari S, Sharifi MD, Reihani H, Rostamiani MB, Behmadi M, et al. Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: a randomized triple-blind placebo-controlled clinical trial. Food Sci Nutr. 2021;9:4068\u201375.","journal-title":"Food Sci Nutr"},{"key":"7012_CR263","doi-asserted-by":"publisher","first-page":"464","DOI":"10.4161\/cbt.11.5.14410","volume":"11","author":"KJ Lim","year":"2011","unstructured":"Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther. 2011;11:464\u201373.","journal-title":"Cancer Biol Ther"},{"key":"7012_CR264","doi-asserted-by":"publisher","first-page":"1509045","DOI":"10.3389\/fphar.2025.1509045","volume":"16","author":"M Hao","year":"2025","unstructured":"Hao M, Zhang C, Wang T, Hu H. Pharmacological effects, formulations, and clinical research progress of curcumin. Front Pharm. 2025;16:1509045.","journal-title":"Front Pharm"},{"key":"7012_CR265","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04824-y","volume":"21","author":"M Hassaniazad","year":"2020","unstructured":"Hassaniazad M, Inchehsablagh BR, Kamali H, Tousi A, Eftekhar E, Jaafari MR, et al. The clinical effect of nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:876.","journal-title":"Trials"},{"key":"7012_CR266","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1080\/10717544.2022.2064564","volume":"29","author":"X Li","year":"2022","unstructured":"Li X, Li S, Ma C, Li T, Yang L. Preparation of baicalin-loaded ligand-modified nanoparticles for nose-to-brain delivery for neuroprotection in cerebral ischemia. Drug Deliv. 2022;29:1282\u201398.","journal-title":"Drug Deliv"},{"key":"7012_CR267","doi-asserted-by":"publisher","first-page":"115003","DOI":"10.1016\/j.addr.2023.115003","volume":"200","author":"AK Pandya","year":"2023","unstructured":"Pandya AK, Vora LK, Umeyor C, Surve D, Patel A, Biswas S, et al. Polymeric in situ forming depots for long-acting drug delivery systems. Adv Drug Deliv Rev. 2023;200:115003.","journal-title":"Adv Drug Deliv Rev"},{"key":"7012_CR268","doi-asserted-by":"publisher","first-page":"833456","DOI":"10.3389\/fbioe.2022.833456","volume":"10","author":"S Parashar","year":"2022","unstructured":"Parashar S, Chauhan C, Rajasekharan A, Rautela J, Jain T, Raza K. An Augmented Method for Collecting PLGA Nanoparticles and the Fabrication of 1, 3, 4, 6-Tetra-Oacetyl-2-azido-2-deoxy-D-glucopyranose (Ac42AzGlc)-Loaded PLGA Nanoparticles for Efficient and Prospective in Vivo Metabolic Processing. Front Bioeng Biotechnol. 2022;10:833456.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR269","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1080\/10717544.2020.1797237","volume":"27","author":"HS Elsewedy","year":"2020","unstructured":"Elsewedy HS, Dhubiab B, Mahdy MA, Elnahas HM. Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles. Drug Deliv. 2020;27:1134\u201346.","journal-title":"Drug Deliv"},{"key":"7012_CR270","first-page":"51015.","volume":"27","author":"RL McCall","year":"2013","unstructured":"McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp. 2013;27:51015.","journal-title":"J Vis Exp"},{"key":"7012_CR271","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"J Shi","year":"2017","unstructured":"Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20\u201337.","journal-title":"Nat Rev Cancer"},{"key":"7012_CR272","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1021\/acs.oprd.9b00387","volume":"23","author":"J Bresseleers","year":"2019","unstructured":"Bresseleers J, Bagheri M, Storm G, Metselaar JM, Hennink WE, Meeuwissen SA, et al. Scale-up of the manufacturing process to produce docetaxel-loaded mPEG-b-p(HPMA-Bz) block copolymer micelles for pharmaceutical applications. Org Process Res Dev. 2019;23:2707\u201315.","journal-title":"Org Process Res Dev"},{"key":"7012_CR273","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/biom12060784","volume":"12","author":"F Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez F, Caruana P, De la Fuente N, Espa\u00f1ol P, G\u00e1mez M, Balart J, et al. Nano-based approved pharmaceuticals for cancer treatment: present and future challenges. Biomolecules. 2022;12:784.","journal-title":"Biomolecules"},{"key":"7012_CR274","doi-asserted-by":"publisher","first-page":"e1944","DOI":"10.1002\/wnan.1944","volume":"16","author":"N Blanco-Cabra","year":"2024","unstructured":"Blanco-Cabra N, Alc\u00e0cer-Almansa J, Admella J, Ar\u00e9valo-Jaimes BV, Torrents E. Nanomedicine against biofilm infections: a roadmap of challenges and limitations. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024;16:e1944.","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"7012_CR275","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2012.06.002","volume":"163","author":"SB Lim","year":"2012","unstructured":"Lim SB, Banerjee A, \u00d6ny\u00fcksel H. Improvement of drug safety by the use of lipid-based nanocarriers. J Control Release. 2012;163:34\u201345.","journal-title":"J Control Release"},{"key":"7012_CR276","doi-asserted-by":"publisher","first-page":"459","DOI":"10.4103\/1735-5362.268207","volume":"14","author":"P Shokoohinia","year":"2019","unstructured":"Shokoohinia P, Hajialyani M, Sadrjavadi K, Akbari M, Rahimi M, Khaledian S, et al. Microfluidic-assisted preparation of PLGA nanoparticles for drug delivery purposes: experimental study and computational fluid dynamic simulation. Res Pharm Sci. 2019;14:459\u201370.","journal-title":"Res Pharm Sci"},{"key":"7012_CR277","first-page":"100030","volume":"1","author":"S Streck","year":"2019","unstructured":"Streck S, Neumann H, Nielsen HM, Rades T, McDowell A. Comparison of bulk and microfluidics methods for the formulation of poly-lactic-co-glycolic acid (PLGA) nanoparticles modified with cell-penetrating peptides of different architectures. Int J Pharm X. 2019;1:100030.","journal-title":"Int J Pharm X"},{"key":"7012_CR278","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1039\/D3AN01739G","volume":"149","author":"Y Shen","year":"2024","unstructured":"Shen Y, Gwak H, Han B. Advanced manufacturing of nanoparticle formulations of drugs and biologics using microfluidics. Analyst. 2024;149:614\u201337.","journal-title":"Analyst"},{"key":"7012_CR279","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/pharmaceutics14020276","volume":"14","author":"MC Operti","year":"2022","unstructured":"Operti MC, Bernhardt A, Sincari V, Jager E, Grimm S, Engel A, et al. Industrial scale manufacturing and downstream processing of PLGA-based nanomedicines suitable for fully continuous operation. Pharmaceutics. 2022;14:276.","journal-title":"Pharmaceutics"},{"key":"7012_CR280","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jsps.2014.04.007","volume":"24","author":"KM Raghava Srivalli","year":"2016","unstructured":"Raghava Srivalli KM, Mishra B. Drug nanocrystals: a way toward scale-up. Saudi Pharm J. 2016;24:386\u2013404.","journal-title":"Saudi Pharm J"},{"key":"7012_CR281","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3390\/jfb15050127","volume":"15","author":"H Yang","year":"2024","unstructured":"Yang H, Gao Y, Liu M, Ma J, Lu Q. Process optimization of scaled-up production and biosafety evaluation of the dimethyl-dioctadecyl-ammonium bromide\/poly(lactic acid) nano-vaccine. J Funct Biomater. 2024;15:127.","journal-title":"J Funct Biomater"},{"key":"7012_CR282","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/molecules28010010","volume":"28","author":"W Alshaer","year":"2022","unstructured":"Alshaer W, Nsairat H, Lafi Z, Hourani OM, Al-Kadash A, Esawi E, et al. Quality by design approach in liposomal formulations: robust product development. Molecules. 2022;28:10.","journal-title":"Molecules"},{"key":"7012_CR283","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/pharmaceutics15020514","volume":"15","author":"J Pielenhofer","year":"2023","unstructured":"Pielenhofer J, Meiser SL, Gogoll K, Ciciliani AM, Denny M, Klak M, et al. Quality by design (QbD) approach for a nanoparticulate imiquimod formulation as an investigational medicinal product. Pharmaceutics. 2023;15:514.","journal-title":"Pharmaceutics"},{"key":"7012_CR284","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3390\/pharmaceutics13020198","volume":"13","author":"S Bochicchio","year":"2021","unstructured":"Bochicchio S, Lamberti G, Barba AA. Polymer-lipid pharmaceutical nanocarriers: innovations by new formulations and production technologies. Pharmaceutics. 2021;13:198.","journal-title":"Pharmaceutics"},{"key":"7012_CR285","doi-asserted-by":"publisher","unstructured":"Shi Y, Lammers T, Storm G, Hennink WE. Physico-chemical strategies to enhance stability and drug retention of polymeric micelles for tumor-targeted drug delivery. Macromol Biosci. 2017;17. https:\/\/doi.org\/10.1002\/mabi.201600160.","DOI":"10.1002\/mabi.201600160"},{"key":"7012_CR286","doi-asserted-by":"publisher","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","volume":"88","author":"B-M Chen","year":"2016","unstructured":"Chen B-M, Su YC, Chang CJ, Burnouf PA, Chuang KH, Chen CH, et al. Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals. Anal Chem. 2016;88:10661\u20136.","journal-title":"Anal Chem"},{"key":"7012_CR287","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.comtox.2022.100223","volume":"22","author":"KM Crofton","year":"2022","unstructured":"Crofton KM, Bassan A, Behl M, Chushak YG, Fritsche E, Gearhart JM, et al. Current status and future directions for a neurotoxicity hazard assessment framework that integrates in silico approaches. Comput Toxicol. 2022;22:100223.","journal-title":"Comput Toxicol"},{"key":"7012_CR288","doi-asserted-by":"publisher","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","volume":"16","author":"Y Ju","year":"2022","unstructured":"Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, et al. Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine. ACS Nano. 2022;16:11769\u201380.","journal-title":"ACS Nano"},{"key":"7012_CR289","doi-asserted-by":"publisher","first-page":"105505","DOI":"10.1016\/j.envint.2020.105505","volume":"137","author":"D Romeo","year":"2020","unstructured":"Romeo D, Salieri B, Hischier R, Nowack B, Wick P. An integrated pathway based on in vitro data for the human hazard assessment of nanomaterials. Environ Int. 2020;137:105505.","journal-title":"Environ Int"},{"key":"7012_CR290","doi-asserted-by":"publisher","first-page":"230","DOI":"10.3390\/nano9020230","volume":"9","author":"D Chirio","year":"2019","unstructured":"Chirio D, Peira E, Dianzani C, Muntoni E, Gigliotti CL, Ferrara B, et al. Development of solid lipid nanoparticles by cold dilution of microemulsions: curcumin loading, preliminary in vitro studies, and biodistribution. Nanomaterials. 2019;9:230.","journal-title":"Nanomaterials"},{"key":"7012_CR291","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.2147\/IJN.S363237","volume":"17","author":"Y Wei","year":"2022","unstructured":"Wei Y, Li K, Zhao W, He Y, Shen H, Yuan J, et al. The effects of a novel curcumin derivative loaded long-circulating solid lipid nanoparticle on the MHCC-97H liver cancer cells and pharmacokinetic behavior. Int J Nanomed. 2022;17:2225\u201341.","journal-title":"Int J Nanomed"},{"key":"7012_CR292","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.2147\/IJN.S267007","volume":"15","author":"J Fonseca-Gomes","year":"2020","unstructured":"Fonseca-Gomes J, Loureiro JA, Tanqueiro SR, Mouro FM, Ruivo P, Carvalho T, et al. In vivo bio-distribution and toxicity evaluation of polymeric and lipid-based nanoparticles: a potential approach for chronic diseases treatment. Int J Nanomed. 2020;15:8609\u201321.","journal-title":"Int J Nanomed"},{"key":"7012_CR293","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/ph17091190","volume":"17","author":"K Pei","year":"2024","unstructured":"Pei K, Georgi M, Hill D, Lam C, Wei W, Cordeiro MF. Review: Neuroprotective nanocarriers in glaucoma. Pharmaceuticals. 2024;17:1190.","journal-title":"Pharmaceuticals"},{"key":"7012_CR294","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2217\/nnm-2020-0469","volume":"16","author":"N Fatima","year":"2021","unstructured":"Fatima N, Akcan U, Kaya M, Gromnicova R, Loughlin J, Sharrack B, et al. Tissue distribution and cellular localization of gold nanocarriers with bound oligonucleotides. Nanomedicine. 2021;16:709\u201320.","journal-title":"Nanomedicine"},{"key":"7012_CR295","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s13346-022-01208-4","volume":"12","author":"WH De Jong","year":"2022","unstructured":"De Jong WH, Geertsma RE, Borchard G. Regulatory safety evaluation of nanomedical products: key issues to refine. Drug Deliv Transl Res. 2022;12:2042\u20137.","journal-title":"Drug Deliv Transl Res"},{"key":"7012_CR296","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fchem.2018.00360","volume":"6","author":"S Soares","year":"2018","unstructured":"Soares S, Sousa J, Pais A, Vitorino C. Nanomedicine: Principles, Properties, and Regulatory Issues. Front Chem. 2018;6:360.","journal-title":"Front Chem"},{"key":"7012_CR297","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1039\/D0BM00558D","volume":"8","author":"R Foulkes","year":"2020","unstructured":"Foulkes R, Man E, Thind J, Yeung S, Joy A, Hoskins C. The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives. Biomater Sci. 2020;8:4653\u201364.","journal-title":"Biomater Sci"},{"key":"7012_CR298","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s11671-023-03913-6","volume":"18","author":"PR Kumbhar","year":"2023","unstructured":"Kumbhar PR, Kumar P, Lasure A, Velayutham R, Mandal D. An updated landscape on nanotechnology-based drug delivery, immunotherapy, vaccinations, imaging, and biomarker detections for cancers: recent trends and future directions with clinical success. Discov Nano. 2023;18:156.","journal-title":"Discov Nano"},{"key":"7012_CR299","doi-asserted-by":"publisher","first-page":"612659","DOI":"10.3389\/fphar.2021.612659","volume":"12","author":"MG Tirumala","year":"2021","unstructured":"Tirumala MG, Anchi P, Raja S, Rachamalla M, Godugu C. Novel Methods and Approaches for Safety Evaluation of Nanoparticle Formulations: A Focus Towards In Vitro Models and Adverse Outcome Pathways. Front Pharmacol. 2021;12:612659.","journal-title":"Front Pharmacol"},{"key":"7012_CR300","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1002\/mco2.327","volume":"4","author":"L Xuan","year":"2023","unstructured":"Xuan L, Ju Z, Skonieczna M, Zhou PK, Huang R. Nanoparticles-induced potential toxicity on human health: applications, toxicity mechanisms, and evaluation models. MedComm. 2023;4:e327.","journal-title":"MedComm"},{"key":"7012_CR301","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","volume":"41","author":"GT Kozma","year":"2023","unstructured":"Kozma GT, M\u00e9sz\u00e1ros T, Ber\u00e9nyi P, Facsk\u00f3 R, Patk\u00f3 Z, Ol\u00e1h CZ, et al. Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG. Vaccine. 2023;41:4561\u201370.","journal-title":"Vaccine"},{"key":"7012_CR302","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fbioe.2020.00258","volume":"8","author":"M Schmutz","year":"2020","unstructured":"Schmutz M, Borges O, Jesus S, Borchard G, Perale G, Zinn M, et al. A Methodological Safe-by-Design Approach for the Development of Nanomedicines. Front Bioeng Biotechnol. 2020;8:258.","journal-title":"Front Bioeng Biotechnol"},{"key":"7012_CR303","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/pharmaceutics16101328","volume":"16","author":"DR Serrano","year":"2024","unstructured":"Serrano DR, Luciano FC, Anaya BJ, Ongoren B, Kara A, Molina G, et al. Artificial intelligence (AI) applications in drug discovery and drug delivery: revolutionizing personalized medicine. Pharmaceutics. 2024;16:1328.","journal-title":"Pharmaceutics"},{"key":"7012_CR304","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-50876-w","volume":"14","author":"S Rezvantalab","year":"2024","unstructured":"Rezvantalab S, Mihandoost S, Rezaiee M. Machine learning assisted exploration of the influential parameters on the PLGA nanoparticles. Sci Rep. 2024;14:1114.","journal-title":"Sci Rep"},{"key":"7012_CR305","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/ph17060677","volume":"17","author":"K Hristova-Panusheva","year":"2024","unstructured":"Hristova-Panusheva K, Xenodochidis C, Georgieva M, Krasteva N. Nanoparticle-mediated drug delivery systems for precision targeting in oncology. Pharmaceuticals. 2024;17:677.","journal-title":"Pharmaceuticals"},{"key":"7012_CR306","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3390\/ijms24010752","volume":"24","author":"JP Smith","year":"2023","unstructured":"Smith JP, Chen W, Shivapurkar N, Gerber M, Tucker RD, Kallakury B, et al. Target-specific nanoparticle polyplex down-regulates mutant Kras to prevent pancreatic carcinogenesis and halt tumor progression. Int J Mol Sci. 2023;24:752.","journal-title":"Int J Mol Sci"},{"key":"7012_CR307","doi-asserted-by":"publisher","first-page":"1444437","DOI":"10.3389\/fimmu.2024.1444437","volume":"15","author":"Z Song","year":"2024","unstructured":"Song Z, Tao Y, Liu Y, Li J. Advances in delivery systems for CRISPR\/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Front Immunol. 2024;15:1444437.","journal-title":"Front Immunol"},{"key":"7012_CR308","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3390\/pharmaceutics13091428","volume":"13","author":"D Luo","year":"2021","unstructured":"Luo D, Xu X, Iqbal MZ, Zhao Q, Zhao R, Farheen J, et al. siRNA-loaded hydroxyapatite nanoparticles for KRAS gene silencing in anti-pancreatic cancer therapy. Pharmaceutics. 2021;13:1428.","journal-title":"Pharmaceutics"},{"key":"7012_CR309","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02627-w","volume":"22","author":"L Lei","year":"2024","unstructured":"Lei L, Pan W, Shou X, Shao Y, Ye S, Zhang J, et al. Nanomaterials-assisted gene editing and synthetic biology for optimizing the treatment of pulmonary diseases. J Nanobiotechnology. 2024;22:343.","journal-title":"J Nanobiotechnology"},{"key":"7012_CR310","doi-asserted-by":"publisher","first-page":"673286","DOI":"10.3389\/fgene.2021.673286","volume":"12","author":"L Duan","year":"2021","unstructured":"Duan L, Ouyang K, Xu X, Xu L, Wen C, Zhou X, et al. Nanoparticle Delivery of CRISPR\/Cas9 for Genome Editing. Front Genet. 2021;12:673286.","journal-title":"Front Genet"},{"key":"7012_CR311","first-page":"64324","volume":"16","author":"A Balasubramanian","year":"2024","unstructured":"Balasubramanian A, Veluswami K, Rao S, Aggarwal S, Mani S. Exploring clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) as a therapeutic modality for cancer: a scoping review. Cureus. 2024;16:64324.","journal-title":"Cureus"},{"key":"7012_CR312","first-page":"4391","volume":"7","author":"NR Jabir","year":"2012","unstructured":"Jabir NR, Tabrez S, Ashraf GM, Shakil S, Damanhouri GA, Kamal MA. Nanotechnology-based approaches in anticancer research. Int J Nanomed. 2012;7:4391\u2013408.","journal-title":"Int J Nanomed"},{"key":"7012_CR313","doi-asserted-by":"publisher","first-page":"1363346","DOI":"10.3389\/fphar.2024.1363346","volume":"15","author":"J Zhang","year":"2024","unstructured":"Zhang J, Li Y, Guo S, Zhang W, Fang B, Wang S. Moving beyond traditional therapies: the role of nanomedicines in lung cancer. Front Pharmacol. 2024;15:1363346.","journal-title":"Front Pharmacol"},{"key":"7012_CR314","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/pharmaceutics14020279","volume":"14","author":"MJ Ramalho","year":"2022","unstructured":"Ramalho MJ, Loureiro JA, Coelho M, Pereira MC. Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma. Pharmaceutics. 2022;14:279.","journal-title":"Pharmaceutics"},{"key":"7012_CR315","doi-asserted-by":"publisher","first-page":"23784","DOI":"10.3390\/ijms161023784","volume":"16","author":"F Jiang","year":"2015","unstructured":"Jiang F, Liu B, Lu J, Li F, Li D, Liang C, et al. Progress and challenges in developing aptamer-functionalized targeted drug delivery systems. Int J Mol Sci. 2015;16:23784\u2013822.","journal-title":"Int J Mol Sci"},{"key":"7012_CR316","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.3390\/pharmaceutics15082160","volume":"15","author":"A Kondrashov","year":"2023","unstructured":"Kondrashov A, Sapkota S, Sharma A, Riano I, Kurzrock R, Adashek JJ. Antibody-drug conjugates in solid tumor oncology: an effectiveness payday with a targeted payload. Pharmaceutics. 2023;15:2160.","journal-title":"Pharmaceutics"},{"key":"7012_CR317","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07008-8","volume":"20","author":"CM van Tilburg","year":"2020","unstructured":"van Tilburg CM, Witt R, Heiss M, Pajtler KW, Plass C, Poschke I, et al. INFORM2 NivEnt: the first trial of the INFORM2 biomarker driven phase I\/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies. BMC Cancer. 2020;20:523.","journal-title":"BMC Cancer"},{"key":"7012_CR318","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-17-0853","volume":"24","author":"K Chaudhary","year":"2018","unstructured":"Chaudhary K, Poirion OB, Lu L, Garmire LX. Deep learning-based multi-omics integration robustly predicts survival in liver cancer. Clin Cancer Res. 2018;24:1248\u201359.","journal-title":"Clin Cancer Res"},{"key":"7012_CR319","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-017-0030-3","volume":"3","author":"H Hass","year":"2017","unstructured":"Hass H, Masson K, Wohlgemuth S, Paragas V, Allen JE, Sevecka M, et al. Predicting ligand-dependent tumors from multi-dimensional signaling features. NPJ Syst Biol Appl. 2017;3:27.","journal-title":"NPJ Syst Biol Appl"},{"key":"7012_CR320","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3390\/nano12030399","volume":"12","author":"M Murar","year":"2022","unstructured":"Murar M, Albertazzi L, Pujals S. Advanced optical imaging-guided nanotheranostics towards personalized cancer drug delivery. Nanomaterials. 2022;12:399.","journal-title":"Nanomaterials"},{"key":"7012_CR321","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3390\/pharmaceutics15030959","volume":"15","author":"R De Piano","year":"2023","unstructured":"De Piano R, Caccavo D, Lamberti G, Remaut K, Seynaeve H, Barba AA. A new productive approach and formulative optimization for curcumin nanoliposomal delivery systems. Pharmaceutics. 2023;15:959.","journal-title":"Pharmaceutics"},{"key":"7012_CR322","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1039\/C7SC04004K","volume":"9","author":"M Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment\/imaging of cancers. Chem Sci. 2018;9:790\u2013810.","journal-title":"Chem Sci"},{"key":"7012_CR323","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/IJN.S146315","volume":"12","author":"FU Din","year":"2017","unstructured":"Din FU, Aman W, Ullah I, Qureshi OS, Mustapha O, Shafique S, et al. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors. Int J Nanomed. 2017;12:7291\u2013309.","journal-title":"Int J Nanomed"},{"key":"7012_CR324","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10829-y","volume":"23","author":"E Thivat","year":"2023","unstructured":"Thivat E, Casile M, Moreau J, Molnar I, Dufort S, Seddik K, et al. Phase I\/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol). BMC Cancer. 2023;23:344.","journal-title":"BMC Cancer"},{"key":"7012_CR325","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jpm7010001","volume":"7","author":"M Antoniou","year":"2017","unstructured":"Antoniou M, Kolamunnage-Dona R, Jorgensen A. Biomarker-guided non-adaptive trial designs in phase II and phase III: a methodological review. J Pers Med. 2017;7:1.","journal-title":"J Pers Med"},{"key":"7012_CR326","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1039\/D3TB02752J","volume":"12","author":"S Madhan","year":"2024","unstructured":"Madhan S, Dhar R, Devi A. Plant-derived exosomes: a green approach for cancer drug delivery. J Mater Chem B. 2024;12:2236\u201352.","journal-title":"J Mater Chem B"},{"key":"7012_CR327","doi-asserted-by":"publisher","first-page":"804","DOI":"10.2174\/0122117385305245240424093014","volume":"13","author":"S Dutta","year":"2025","unstructured":"Dutta S, Ghosh S, Rahaman M, Chowdhary SR. Plant-derived exosomes: pioneering breakthroughs in therapeutics, targeted drug delivery, and regenerative medicine. Pharm Nanotechnol. 2025;13:804\u201326.","journal-title":"Pharm Nanotechnol"},{"key":"7012_CR328","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/biom13050839","volume":"13","author":"FA Alzahrani","year":"2023","unstructured":"Alzahrani FA, Khan MI, Kameli N, Alsahafi E, Riza YM. Plant-derived extracellular vesicles and their exciting potential as the future of next-generation drug delivery. Biomolecules. 2023;13:839.","journal-title":"Biomolecules"},{"key":"7012_CR329","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/pharmaceutics14040822","volume":"14","author":"Y Cai","year":"2022","unstructured":"Cai Y, Zhang L, Zhang Y, Lu R. Plant-derived exosomes as a drug-delivery approach for the treatment of inflammatory bowel disease and colitis-associated cancer. Pharmaceutics. 2022;14:822.","journal-title":"Pharmaceutics"},{"key":"7012_CR330","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.3390\/nano12183201","volume":"12","author":"J Venkatas","year":"2022","unstructured":"Venkatas J, Daniels A, Singh M. The potential of curcumin-capped nanoparticle synthesis in cancer therapy: a green synthesis approach. Nanomaterials. 2022;12:3201.","journal-title":"Nanomaterials"},{"key":"7012_CR331","doi-asserted-by":"publisher","first-page":"9280","DOI":"10.1021\/jf202135j","volume":"59","author":"X Xie","year":"2011","unstructured":"Xie X, Tao Q, Zou Y, Zhang F, Guo M, Wang Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem. 2011;59:9280\u20139.","journal-title":"J Agric Food Chem"},{"key":"7012_CR332","doi-asserted-by":"publisher","first-page":"7257","DOI":"10.1021\/acsomega.1c07006","volume":"7","author":"VA Stepanova","year":"2022","unstructured":"Stepanova VA, Guerrero A, Schull C, Christensen J, Trudeau C, Cook J, et al. Hybrid synthetic and computational study of an optimized, solvent-free approach to curcuminoids. ACS Omega. 2022;7:7257\u201377.","journal-title":"ACS Omega"},{"key":"7012_CR333","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00413-7","volume":"27","author":"AP Dayanandan","year":"2023","unstructured":"Dayanandan AP, Cho WJ, Kang H, Bello AB, Kim BJ, Arai Y, et al. Emerging nano-scale delivery systems for the treatment of osteoporosis. Biomater Res. 2023;27:68.","journal-title":"Biomater Res"},{"key":"7012_CR334","doi-asserted-by":"publisher","first-page":"12410","DOI":"10.1021\/acsomega.0c05246","volume":"6","author":"DA Pati\u00f1o-Ruiz","year":"2021","unstructured":"Pati\u00f1o-Ruiz DA, Meramo-Hurtado SI, Gonz\u00e1lez-Delgado \u00c1D, Herrera A. Environmental sustainability evaluation of iron oxide nanoparticles synthesized via green synthesis and the coprecipitation method: a comparative life cycle assessment study. ACS Omega. 2021;6:12410\u201323.","journal-title":"ACS Omega"},{"key":"7012_CR335","doi-asserted-by":"publisher","first-page":"1400375","DOI":"10.3389\/fchem.2024.1400375","volume":"12","author":"D Parajuli","year":"2024","unstructured":"Parajuli D. MXenes-polymer nanocomposites for biomedical applications: fundamentals and future perspectives. Front Chem. 2024;12:1400375.","journal-title":"Front Chem"},{"key":"7012_CR336","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3390\/pharmaceutics15030922","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Poon K, Masonsong G, Ramaswamy Y, Singh G. Sustainable nanomaterials for biomedical applications. Pharmaceutics. 2023;15:922.","journal-title":"Pharmaceutics"},{"key":"7012_CR337","doi-asserted-by":"publisher","first-page":"14347","DOI":"10.1021\/acsnano.3c03925","volume":"17","author":"H Wang","year":"2023","unstructured":"Wang H, Li Q, Alam P, Bai H, Bhalla V, Bryce MR, et al. Aggregation-induced emission (AIE), life and health. ACS Nano. 2023;17:14347\u2013405.","journal-title":"ACS Nano"},{"key":"7012_CR338","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/j.impact.2021.100335","volume":"23","author":"B Salieri","year":"2021","unstructured":"Salieri B, Barruetabe\u00f1a L, Rodr\u00edguez-Llopis I, Jacobsen NR, Manier N, Trouiller B, et al. Integrative approach in a safe by design context combining risk, life cycle and socio-economic assessment for safer and sustainable nanomaterials. NanoImpact. 2021;23:100335.","journal-title":"NanoImpact"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-026-07012-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-026-07012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T09:03:09Z","timestamp":1770800589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-026-07012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":338,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7012"],"URL":"https:\/\/doi.org\/10.1007\/s10856-026-07012-7","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"38"}}